rfhg_61484.1

Basic information about the TSS

---

TSS ID: rfhg_61484.1 Species: human Chr: chr4		Start: 113762257 End: 113762275 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3616920,EH38E2321512)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000296402.9:330 GeneID: 817 HGNC/MGI_ID: HGNC:1462 UniProt_ID: Q13557 Nearer transcript ids and distances:

Gene_name: calcium/calmodulin dependent protein kinase II delta Gene_symbol: CAMK2D Gene_synonyms: Gene_source: HGNC:1462

TATA-Box annotation

---

Distance to TSS:	-339
Nearest PromoterID:	NM_172129
Entrez ID:	817
Nearest Unigene:	Hs.144114
Nearest Refseq:	NM_001221
Nearest Ensembl:	ENSG00000145349
Gene Name:	calcium/calmodulin dependent protein kinase II delta
Gene Alias:	CAMKD
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.578947
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CAMK2D p2@CAMK2D p3@CAMK2D p4@CAMK2D p5@CAMK2D p6@CAMK2D p7@CAMK2D p8@CAMK2D p9@CAMK2D p10@CAMK2D
Sample		p1@CAMK2D	p2@CAMK2D	p3@CAMK2D	p4@CAMK2D	p5@CAMK2D	p6@CAMK2D	p7@CAMK2D	p8@CAMK2D	p9@CAMK2D	p10@CAMK2D
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	14.22	0.39	0.39	1.36	0.19	0.00	0.19	0.19	0.00	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	12.14	0.81	0.40	1.21	0.81	0.40	0.00	0.00	0.20	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	12.73	0.00	0.00	1.35	0.19	0.00	0.39	0.00	0.19	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	12.89	0.83	0.00	0.83	0.42	0.00	0.21	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	10.57	0.45	0.00	0.90	0.45	0.22	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	11.63	0.00	0.00	0.97	0.78	0.00	0.19	0.19	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	13.94	0.44	0.22	0.87	1.31	0.22	0.22	0.87	0.22	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	10.90	0.00	0.48	0.97	0.73	0.00	0.00	0.00	0.00	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	11.33	0.00	0.64	0.85	0.21	0.21	0.43	0.00	0.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	14.49	0.00	0.58	2.90	1.16	0.58	0.58	0.00	1.16	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	11.72	0.00	0.40	1.62	1.21	0.40	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	14.23	0.41	1.22	0.41	1.22	0.00	0.00	0.81	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	44.17	1.93	1.61	6.45	0.32	0.32	0.32	0.32	0.32	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	29.77	2.26	0.90	4.51	0.15	0.30	0.30	0.00	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	36.23	2.20	1.32	5.71	0.44	0.44	0.22	0.22	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	36.72	1.01	1.26	4.02	0.25	0.50	0.00	0.25	0.00	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	33.85	1.53	0.87	2.84	0.22	0.00	0.22	0.22	0.66	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	37.54	1.27	0.84	3.37	0.42	0.42	0.42	0.42	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	33.59	1.60	1.07	4.80	0.53	0.00	0.53	0.53	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	34.30	1.65	1.96	5.27	0.45	0.30	0.30	0.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	30.07	0.80	1.87	4.14	0.94	0.40	0.27	0.13	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	28.31	2.42	0.86	3.45	0.17	0.17	0.52	0.17	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	28.31	1.55	1.03	2.84	0.65	0.00	0.13	0.39	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	29.85	0.97	0.73	3.64	0.24	0.49	0.73	0.49	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	32.76	1.03	1.29	3.61	0.26	0.26	0.00	0.26	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	30.07	0.00	0.95	3.48	0.00	0.32	0.32	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	29.12	0.55	1.65	2.75	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	30.41	1.65	0.94	3.54	0.47	0.24	0.00	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	26.97	0.97	1.13	4.85	0.32	0.00	0.16	0.00	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	31.13	1.09	0.90	4.34	0.72	0.00	0.54	0.18	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	30.56	0.21	1.47	2.09	0.00	0.63	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	30.67	0.98	0.78	2.34	0.78	0.00	0.00	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	25.53	1.27	1.06	2.95	0.42	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	23.92	1.65	0.99	2.31	0.49	0.49	0.00	0.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	28.98	1.68	1.12	4.86	0.00	0.19	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	32.38	0.77	0.96	2.49	0.38	0.00	0.00	0.57	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	26.98	1.64	0.82	3.47	0.61	0.20	0.00	0.00	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	21.96	1.61	1.21	3.63	0.00	0.00	0.20	0.00	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	23.23	1.89	0.54	1.62	0.00	0.27	0.27	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	23.05	0.72	2.16	2.88	0.00	0.24	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	21.41	0.94	0.71	2.82	0.71	0.24	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	17.13	0.73	0.59	3.81	0.15	0.15	0.29	0.59	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	25.52	1.27	0.84	4.64	0.63	0.00	0.42	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	25.35	1.05	0.70	2.97	0.00	0.00	0.00	0.00	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	27.51	0.80	0.40	3.61	0.00	0.20	0.00	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	18.84	1.16	0.70	2.79	0.47	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	19.67	0.48	1.68	2.16	0.00	0.48	0.00	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	22.65	0.30	0.30	1.79	0.30	0.30	0.60	0.00	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	15.56	1.91	1.20	3.11	0.24	0.00	0.48	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	16.58	0.20	0.61	2.22	0.00	0.00	0.20	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	17.22	0.41	0.61	1.84	0.00	0.41	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	13.34	0.67	0.44	0.89	0.00	0.00	0.00	0.22	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	12.07	1.06	0.35	1.42	0.00	0.35	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	5.96	0.00	0.99	0.66	0.00	0.00	0.33	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	3.36	1.68	0.84	0.84	0.84	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	10.56	0.00	0.00	0.92	0.92	0.00	0.46	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	11.67	0.65	0.00	0.97	0.32	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	16.38	0.00	0.64	1.93	0.00	0.32	0.00	0.00	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	11.00	0.63	0.94	0.94	0.00	0.31	0.31	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	6.35	0.00	1.41	1.41	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	5.61	0.56	0.00	1.68	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	11.15	0.80	0.00	0.80	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	6.12	0.00	0.00	1.36	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	10.72	0.00	0.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	3.90	0.35	0.00	0.71	0.35	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	16.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	0.00	0.00	0.00	7.90	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	6.83	0.00	0.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	8.93	0.50	0.00	1.98	0.00	0.00	0.50	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	13.60	0.00	0.00	2.81	0.47	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	28.81	0.00	0.33	3.64	0.33	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	26.29	0.62	0.93	2.78	0.00	0.00	0.31	0.31	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	24.46	0.31	0.61	2.14	0.00	0.00	0.31	0.00	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	23.60	5.07	3.64	1.27	2.22	0.48	2.06	0.95	0.63	0.16
Adipocyte - breast, donor2	11327-117E4	18.45	3.85	3.53	1.76	2.09	1.12	0.96	0.64	0.32	0.00
Adipocyte - omental, donor1	11473-119C6	23.41	3.56	3.56	1.27	4.20	1.78	1.27	0.76	0.89	0.00
Adipocyte - omental, donor2	11474-119C7	11.96	1.49	2.24	0.75	3.74	1.49	2.24	0.00	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	21.43	2.34	5.69	1.34	3.01	0.33	0.00	0.67	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	26.80	0.00	3.83	0.64	0.64	0.00	1.28	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	3.30	0.00	1.10	0.00	1.10	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	14.45	10.39	4.97	0.00	2.71	2.26	0.45	0.45	0.90	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	22.24	6.78	5.91	0.35	2.43	0.52	1.22	0.17	0.70	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	51.44	14.47	10.95	2.15	4.30	3.91	3.13	0.78	0.78	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	26.77	4.12	3.35	0.77	1.54	1.03	1.03	0.26	0.26	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	32.06	10.31	7.81	1.12	3.90	3.35	2.79	0.28	0.28	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	75.24	20.57	23.51	3.53	11.17	3.53	1.18	0.00	1.76	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	35.55	14.24	11.58	2.49	4.50	2.17	3.86	0.64	0.88	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	46.15	11.94	15.81	2.58	3.23	2.90	1.61	1.29	0.65	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	27.73	12.26	13.86	0.53	2.67	1.07	0.00	0.53	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	26.71	10.02	8.35	1.11	3.90	0.00	3.34	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	22.04	6.24	4.16	0.83	1.66	2.08	2.08	1.25	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	26.62	6.28	8.04	2.76	2.51	1.76	2.01	1.00	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	21.27	6.22	8.18	1.31	4.91	1.31	0.98	0.98	0.65	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	21.31	3.35	7.00	0.91	1.52	0.91	0.61	0.30	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	2.65	0.22	0.22	0.22	0.00	0.00	0.00	0.22	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	3.94	0.00	0.36	0.00	0.00	0.00	0.00	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	23.93	1.08	1.26	1.44	0.90	0.00	0.36	0.18	0.00	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	13.39	3.35	3.35	1.67	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	16.02	1.44	0.82	1.03	0.00	0.21	0.41	0.00	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	44.63	22.08	17.96	2.40	6.52	3.20	1.72	1.49	2.86	0.23
Anulus Pulposus Cell, donor2	11463-119B5	76.66	13.96	15.67	2.45	4.65	2.45	1.47	0.49	2.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	16.17	1.35	0.90	1.35	0.00	0.45	0.00	0.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	22.14	3.91	3.47	0.00	0.43	0.00	0.87	0.43	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	21.40	6.42	2.14	0.00	0.00	2.14	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	12.26	2.69	1.49	0.30	1.20	0.30	1.79	0.30	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	13.91	2.53	3.79	0.00	5.06	0.00	2.53	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	15.84	1.98	2.64	0.66	1.32	0.66	0.66	0.00	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	13.00	0.65	2.27	0.32	0.97	0.32	1.30	0.65	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	12.62	1.94	1.46	0.49	0.97	0.49	0.49	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	13.66	1.78	2.38	0.00	0.00	0.00	0.59	0.59	1.19	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	10.92	4.14	1.13	0.75	1.51	0.00	0.75	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	13.06	3.63	0.73	0.73	0.00	0.73	0.73	0.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	16.30	2.51	0.00	0.00	1.25	0.00	1.25	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	14.17	1.98	2.14	0.66	1.81	0.33	1.15	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	12.28	1.36	2.73	0.00	0.00	0.00	0.00	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	21.56	2.11	3.02	0.90	0.90	0.75	0.45	0.15	0.30	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	16.07	1.07	2.68	0.00	0.00	0.00	1.07	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	14.74	2.65	1.13	0.94	0.94	0.38	1.13	0.38	0.00	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	19.51	1.87	1.60	0.53	0.80	0.27	0.27	0.53	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	18.53	0.98	0.98	0.98	0.00	1.95	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	12.27	4.64	1.66	0.83	1.16	0.17	0.83	1.00	0.33	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	15.61	1.20	2.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	38.94	3.54	0.00	0.00	3.54	0.00	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	14.07	1.72	2.06	0.86	0.00	0.34	1.37	0.17	0.00	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	0.00	4.19	0.00	0.00	0.00	0.00	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	14.56	1.94	3.40	0.00	0.00	0.49	0.97	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	18.59	3.04	3.04	1.90	1.14	0.00	0.00	0.38	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	23.02	2.42	3.63	0.00	0.00	1.21	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	15.39	0.57	1.71	0.00	1.14	0.57	1.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	13.25	2.57	3.63	0.64	1.28	0.21	0.21	0.00	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	20.13	3.61	1.55	0.00	1.29	0.77	1.03	0.52	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	15.48	1.88	3.28	0.47	0.00	0.47	0.47	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	16.08	3.22	2.57	0.32	0.96	0.32	0.96	0.32	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	21.40	2.14	2.14	0.71	1.43	0.00	3.57	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	10.53	2.34	3.51	0.00	1.17	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	16.56	2.71	2.41	0.30	0.30	1.51	0.60	0.30	0.30	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	30.89	1.19	3.56	0.00	0.00	0.00	0.00	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	15.26	2.54	1.02	0.51	0.00	0.51	0.00	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	18.85	3.06	3.57	1.78	1.02	0.76	0.76	1.27	0.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	15.25	2.54	4.45	0.64	0.00	1.91	0.64	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	12.51	2.59	2.16	0.00	1.29	0.00	2.16	0.43	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	13.76	2.96	1.06	1.27	1.27	0.85	0.85	0.64	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	18.85	2.03	1.74	0.58	0.29	0.00	0.87	0.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	12.28	0.00	0.94	2.83	0.94	0.94	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	15.09	3.22	1.70	1.36	0.68	0.51	0.51	0.68	0.17	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	23.16	0.00	2.32	0.00	4.63	0.00	0.00	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	14.79	2.11	2.11	0.00	4.23	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	13.94	1.07	1.29	1.72	0.00	0.43	0.64	0.43	0.43	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	21.66	3.01	2.41	0.60	0.60	0.60	1.80	0.60	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	10.21	2.19	5.10	0.73	0.73	0.73	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	15.40	1.84	2.53	0.69	0.92	0.69	0.92	0.69	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	20.40	0.00	0.00	2.55	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	24.15	4.32	2.80	1.02	2.29	1.27	1.27	0.76	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	14.86	2.27	1.45	1.24	1.24	0.21	0.21	0.41	0.21	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	15.61	2.14	2.45	0.92	0.92	0.61	1.22	0.31	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	11.95	1.91	1.43	0.00	1.43	0.00	0.48	0.48	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	15.08	2.00	1.33	0.44	1.33	0.00	0.89	0.00	0.00	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	9.15	6.10	0.00	0.00	1.53	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	13.29	0.55	1.66	0.00	0.55	0.00	0.55	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	12.18	1.85	1.85	1.32	0.26	0.53	0.26	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	15.63	2.18	1.45	0.00	0.00	1.45	0.00	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	29.72	1.11	2.09	3.19	0.74	0.37	0.37	0.61	0.12	0.00
Astrocyte - cerebellum, donor2	11580-120F5	32.35	1.37	2.74	2.23	0.86	0.17	0.17	0.00	0.00	0.34
Astrocyte - cerebellum, donor3	11661-122F5	22.65	1.05	0.63	1.68	0.21	0.00	0.00	0.00	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	75.29	10.81	6.27	10.46	3.14	0.70	0.35	1.05	1.74	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	93.83	12.29	6.79	6.96	4.85	2.10	1.29	1.29	1.13	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	102.47	9.55	7.16	9.10	3.13	1.19	0.30	0.60	0.75	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	61.01	19.61	8.14	8.60	13.07	4.59	0.92	1.72	1.26	6.08
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	47.48	18.54	8.39	7.89	10.52	3.13	1.13	1.13	1.50	5.26
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	46.66	19.46	8.42	6.71	12.29	4.32	0.91	0.80	0.57	4.21
Basophils, donor1	12241-129G9	8.89	5.23	1.31	1.83	1.31	0.52	0.26	0.26	0.00	0.52
Basophils, donor2	12242-129H1	14.43	5.41	2.89	4.69	0.72	0.72	1.08	0.00	0.00	1.44
Basophils, donor3	12243-129H2	10.88	3.67	2.94	1.03	1.32	0.29	0.59	0.29	0.29	0.73
Bronchial Epithelial Cell, donor1	11511-119G8	12.72	0.43	0.00	1.08	0.00	0.43	0.22	0.43	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	7.77	0.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	8.79	0.00	0.00	0.00	1.26	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	4.78	0.21	0.83	0.83	0.21	0.00	0.42	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	9.90	0.23	0.46	0.23	0.00	0.00	0.00	0.00	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	12.60	0.72	0.72	1.98	0.18	0.00	0.36	0.36	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	130.98	5.77	3.40	6.80	6.18	1.34	0.31	1.03	0.21	1.24
Burkitt's lymphoma cell line:RAJI	10476-106I8	66.38	9.08	1.40	4.89	5.59	0.47	0.00	1.16	0.00	1.40
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	3.20	0.00	0.00	0.00	0.00	0.00	0.32	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	19.16	9.58	8.45	3.94	5.64	2.25	0.56	1.13	0.56	1.69
CD14+ Monocytes, donor2	11305-117B9	10.21	4.45	5.01	1.67	2.23	0.74	1.11	0.00	0.00	1.11
CD14+ Monocytes, donor3	11381-118B4	17.78	8.34	7.03	2.85	2.63	0.88	1.32	0.22	0.22	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	5.09	4.25	4.81	1.42	0.85	0.00	0.85	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	10.61	3.79	2.27	1.14	1.14	0.38	0.38	0.38	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	8.22	4.60	3.94	3.29	0.33	0.00	0.66	0.66	0.00	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	1.59	1.45	1.45	0.00	0.14	0.29	0.43	0.29	0.00	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	3.62	2.11	2.11	0.30	0.30	0.00	0.30	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	2.37	3.32	2.37	1.18	0.47	0.00	0.71	0.00	0.00	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	1.17	1.51	0.84	0.00	0.50	0.00	0.50	0.00	0.00	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	2.21	1.38	1.38	0.28	0.55	0.00	0.28	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	1.74	3.47	2.98	0.25	0.74	0.25	0.25	0.74	0.00	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	1.96	1.57	2.15	0.00	0.20	0.00	0.20	0.39	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	3.03	2.85	3.03	0.18	0.89	0.53	0.71	0.36	0.00	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	4.57	3.92	4.35	0.44	0.87	0.87	2.39	0.22	0.00	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	2.34	2.34	2.58	0.23	0.00	0.23	1.64	0.23	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	2.11	6.34	3.17	0.53	1.06	1.06	0.53	0.53	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	5.55	4.44	2.22	2.22	4.44	1.11	2.22	0.00	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	1.34	0.74	0.59	0.30	0.30	0.45	1.04	0.15	0.30	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	2.39	2.99	1.60	0.40	1.00	0.80	1.00	0.00	0.60	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	3.33	4.16	2.71	0.42	1.25	0.42	1.04	0.21	0.00	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	2.75	0.69	1.14	0.00	0.00	0.46	0.92	0.23	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	2.71	2.49	3.17	0.00	2.04	0.00	0.90	0.00	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	3.06	3.06	0.87	0.00	1.75	0.00	0.87	0.00	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	1.08	1.61	2.15	0.00	0.81	0.00	1.08	0.27	0.54	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	3.66	3.31	2.79	0.52	0.87	0.17	1.22	0.35	0.17	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	7.57	4.21	0.84	0.42	0.42	0.00	0.42	0.84	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	1.65	1.29	2.57	0.00	0.92	0.55	0.73	0.00	0.00	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	2.82	1.41	0.70	0.35	1.76	0.70	0.00	0.35	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	3.51	4.39	1.75	0.00	0.88	0.44	0.88	0.44	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	2.09	1.39	1.05	0.00	0.35	0.17	0.87	0.35	0.00	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	4.46	4.83	3.35	0.37	0.74	0.74	1.49	0.37	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	4.96	4.31	3.88	0.43	1.72	0.43	0.43	0.22	0.22	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	8.19	1.23	3.69	0.82	0.82	0.41	0.41	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	4.17	2.32	3.25	0.23	1.62	0.23	0.70	0.00	0.00	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	5.57	3.02	3.48	0.00	1.62	0.23	1.16	0.00	0.23	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	4.36	3.05	2.83	1.09	1.53	0.22	0.44	0.00	0.00	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	3.00	4.16	3.23	1.15	1.62	0.69	1.39	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	7.15	7.15	5.63	0.22	2.82	1.30	1.08	0.65	0.00	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	7.47	8.41	6.38	0.93	1.71	0.31	2.65	0.62	0.47	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	6.99	6.29	4.02	1.22	1.75	1.57	2.62	0.35	0.35	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	13.82	16.50	9.14	1.56	2.23	2.23	4.68	1.34	0.67	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	2.55	0.77	0.77	1.02	0.51	0.00	0.00	0.26	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	3.29	1.98	2.85	0.66	0.00	0.44	0.44	0.22	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	2.95	3.37	3.16	0.63	0.00	0.00	0.21	0.21	0.21	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	103.65	22.36	18.29	6.10	10.16	2.03	0.00	2.03	0.00	8.13
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	107.12	33.22	10.17	12.20	7.46	2.71	0.68	3.39	0.68	6.10
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	107.70	23.82	20.71	10.36	12.43	1.04	0.00	3.11	3.11	11.39
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	144.45	23.45	19.72	21.85	9.59	3.20	0.53	3.73	0.53	5.86
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	143.67	20.37	19.30	7.50	9.11	1.07	0.00	4.29	0.00	8.58
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	121.44	31.59	18.25	14.04	4.21	3.51	2.81	2.81	1.40	5.62
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	130.20	25.10	10.98	23.53	7.84	5.49	0.78	3.92	0.00	3.92
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	100.19	29.00	18.46	7.91	9.23	3.95	2.64	2.64	1.32	5.27
CD19+ B Cells, donor1	11544-120B5	222.73	24.66	27.12	19.73	9.04	0.82	0.82	4.11	4.11	13.15
CD19+ B Cells, donor2	11624-122B4	126.22	13.78	12.33	6.53	3.63	0.73	2.90	5.80	0.73	7.25
CD19+ B Cells, donor3	11705-123B4	123.68	12.12	9.59	13.13	7.57	0.50	1.01	1.01	0.50	9.59
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	11.04	1.00	0.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	11.80	0.56	3.37	0.00	1.69	0.56	0.00	0.00	0.00	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	1.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	2.25	0.00	0.23	0.23	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	56.77	2.14	2.14	13.21	1.43	0.00	0.71	2.14	0.00	8.21
CD4+ T Cells, donor2	11306-117C1	44.09	1.22	2.45	7.96	0.61	0.00	0.61	3.06	0.00	9.19
CD4+ T Cells, donor3	11382-118B5	53.07	3.66	2.74	7.62	0.30	0.00	1.22	1.22	0.00	6.10
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	37.52	12.25	8.68	6.89	2.04	0.51	0.51	2.55	0.26	4.34
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	37.51	7.64	4.27	3.82	1.80	0.67	1.12	2.47	0.45	6.29
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	54.04	8.62	6.61	5.46	0.86	0.86	0.57	1.72	0.29	7.76
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	61.63	3.79	5.69	8.53	0.95	0.95	0.47	3.32	0.00	8.53
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	59.70	4.21	1.40	7.02	2.11	0.70	2.81	3.51	0.00	10.53
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	65.92	0.00	6.59	3.30	3.30	0.00	0.00	0.00	0.00	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	29.19	4.34	3.18	2.17	0.72	0.29	0.14	1.59	0.29	3.61
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	41.18	4.91	4.58	3.90	0.85	0.00	0.17	0.85	0.17	4.41
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	47.56	3.71	4.84	5.00	0.64	0.32	0.32	2.10	0.00	4.19
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	23.31	4.48	2.69	1.79	0.90	0.00	0.00	0.45	0.00	6.72
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	21.31	5.94	3.14	4.89	0.70	0.00	1.75	0.70	0.00	4.19
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	36.96	9.68	5.28	6.60	2.64	1.32	2.64	1.32	0.44	6.60
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	42.16	4.64	3.79	2.95	0.84	0.42	1.26	2.53	0.42	2.11
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	41.76	4.36	3.74	6.03	1.04	0.21	0.42	1.25	0.42	3.74
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	52.12	2.34	2.00	5.35	0.00	0.00	0.00	0.33	0.00	3.01
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	55.47	1.63	2.45	8.97	0.00	0.27	0.82	1.36	0.27	6.53
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	65.92	1.61	2.68	7.50	1.07	0.00	1.61	2.14	0.00	8.58
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	50.21	1.79	0.00	12.55	0.00	1.79	0.00	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	40.42	5.75	4.26	4.64	0.74	0.19	1.67	0.74	0.00	2.97
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	38.56	4.77	2.82	4.33	1.52	0.65	1.52	0.87	0.00	3.47
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	46.44	5.04	3.36	4.41	0.84	0.84	0.21	0.84	0.00	6.09
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	36.91	3.03	3.03	6.57	0.51	0.00	0.51	2.02	0.00	3.54
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	31.63	6.07	2.17	5.63	0.87	0.87	0.43	2.60	0.00	3.90
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	40.53	7.41	5.23	5.23	1.31	0.00	0.87	2.61	0.44	3.05
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	37.61	4.45	1.98	10.39	0.49	0.49	0.00	1.48	0.00	5.44
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	31.39	4.62	2.77	3.69	0.00	0.00	0.92	0.92	0.00	5.54
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	23.73	4.19	0.00	1.40	0.00	1.40	0.00	1.40	1.40	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	46.80	5.26	4.43	7.75	2.22	0.55	1.94	3.60	0.00	4.98
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	45.64	5.64	5.89	8.83	1.72	0.98	0.98	2.21	0.25	3.93
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	38.50	3.08	4.62	7.70	4.62	0.00	1.54	1.54	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	37.96	5.01	3.94	5.37	0.36	0.72	0.72	2.51	0.36	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	29.08	2.77	2.77	4.15	1.38	2.77	1.38	2.77	0.00	6.92
CD8+ T Cells, donor1	11226-116C2	36.34	5.24	3.27	6.22	1.31	0.00	1.31	0.98	0.00	3.93
CD8+ T Cells, donor2	11307-117C2	24.40	3.00	2.25	6.01	0.75	0.00	0.38	1.88	0.00	4.51
CD8+ T Cells, donor3	11383-118B6	45.95	1.51	2.27	6.82	0.50	0.50	0.76	1.26	0.00	7.83
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	35.56	5.28	2.29	0.92	5.05	1.15	0.46	0.92	0.00	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	29.72	5.27	3.12	1.44	3.35	1.20	1.20	0.96	0.00	1.20
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	30.10	8.21	1.64	1.64	4.92	1.09	0.27	0.82	0.55	1.92
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	24.62	8.11	3.00	1.50	7.51	1.50	0.00	1.50	0.00	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	38.16	5.28	2.16	2.64	4.56	2.64	1.20	0.72	0.48	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	27.06	6.82	2.27	1.36	4.55	1.14	0.23	0.68	0.00	1.14
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	29.12	3.69	2.17	2.61	5.87	0.22	1.74	1.30	0.22	1.96
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	33.95	4.74	3.42	1.84	6.32	2.63	0.00	0.79	0.26	2.37
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	29.78	4.69	2.35	0.94	5.16	1.41	0.47	0.94	0.00	2.81
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	29.89	5.13	3.62	1.21	5.74	1.51	1.51	1.21	0.30	3.62
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	36.31	8.42	2.03	0.87	6.10	2.03	0.29	0.58	0.29	2.03
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	30.11	6.66	3.46	3.73	4.53	2.40	1.33	1.33	0.53	3.20
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	48.15	9.63	3.94	4.82	11.38	2.63	0.88	1.31	0.44	2.19
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	51.01	5.92	9.11	3.64	21.86	3.64	0.91	1.82	0.46	3.19
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	93.23	2.98	3.73	6.71	13.43	1.49	0.00	0.75	0.00	3.73
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	26.65	6.84	1.08	2.52	5.76	1.08	1.08	2.16	0.00	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	30.79	4.89	2.88	0.86	4.32	1.44	1.15	1.15	0.00	1.73
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	28.99	4.48	2.59	0.71	4.48	1.41	0.71	0.47	0.00	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	23.13	7.61	4.44	3.17	6.65	1.27	0.32	0.32	0.00	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	26.14	5.54	1.85	1.85	5.23	1.85	0.31	0.62	0.00	1.85
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	24.04	6.09	3.53	4.49	4.81	0.64	0.64	0.96	0.32	1.60
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	32.13	3.44	0.76	1.91	5.74	1.15	0.38	0.76	0.00	2.68
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	37.05	6.70	2.76	0.79	5.52	0.79	1.18	1.18	0.00	1.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	36.31	9.83	1.51	1.51	7.56	2.27	1.51	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	122.05	14.45	7.23	12.85	17.67	4.82	0.80	3.21	0.80	12.04
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	133.59	11.89	11.19	11.19	21.68	5.60	0.70	2.10	0.00	13.99
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	132.23	19.03	15.03	14.02	23.04	10.02	4.01	0.00	0.00	14.02
Cardiac Myocyte, donor1	11525-119I4	228.47	18.28	38.38	1.83	3.66	5.48	3.66	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	25.69	2.47	4.45	1.48	1.98	0.99	0.99	2.47	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	39.78	7.68	6.00	2.32	2.84	1.79	0.95	0.21	0.21	0.00
Chondrocyte - de diff, donor1	11261-116G1	43.68	6.24	11.79	2.08	3.81	3.81	1.73	0.69	0.69	0.00
Chondrocyte - de diff, donor2	11338-117F6	25.59	23.45	9.24	0.71	5.69	1.42	1.78	0.71	1.07	0.00
Chondrocyte - de diff, donor3	11410-118E6	36.52	12.74	8.99	1.37	3.41	2.73	2.05	0.91	0.57	0.00
Chondrocyte - re diff, donor2	11339-117F7	26.86	7.16	8.06	1.79	3.58	0.90	0.00	1.79	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	48.53	6.47	4.85	2.83	1.62	0.81	1.62	2.02	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	47.17	5.39	4.82	4.59	1.15	1.15	0.57	0.69	0.23	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	29.71	4.92	2.57	2.35	1.07	0.43	0.21	0.43	0.86	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	26.90	2.30	1.59	2.65	0.53	0.35	0.44	0.44	0.18	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	30.90	5.87	3.21	4.22	0.92	1.01	0.83	1.10	0.28	0.09
Corneal Epithelial Cells, donor1	11526-119I5	3.51	0.00	0.44	0.66	0.00	0.00	0.22	0.44	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	9.10	0.00	0.00	2.28	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	9.20	0.26	0.51	0.77	0.26	0.00	0.26	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	12.71	11.23	6.11	1.32	2.48	0.99	0.66	0.50	0.83	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	8.20	14.19	5.99	1.26	2.84	3.15	0.63	0.95	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	6.90	6.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	7.56	5.08	3.35	0.76	1.19	0.97	0.76	0.43	0.32	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	2.73	0.68	0.34	0.00	0.00	0.34	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	3.26	2.61	0.00	1.31	0.65	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	1.45	0.48	0.00	0.48	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	6.34	2.17	1.00	0.67	0.83	0.67	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	7.04	1.76	1.76	0.59	1.17	0.59	0.00	0.00	0.00	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	6.79	0.57	1.70	0.00	0.57	0.28	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	12.98	2.75	1.18	1.57	0.79	0.00	0.00	0.00	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	4.36	0.58	0.29	0.29	0.87	0.29	0.00	0.29	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	4.47	0.94	0.71	0.71	0.00	0.00	0.00	0.00	0.24	0.00
Endothelial Cells - Artery, donor3	11413-118E9	3.68	1.23	0.35	0.70	0.53	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	21.94	8.42	6.43	0.89	2.66	1.55	0.22	0.00	0.44	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	29.82	9.43	7.30	1.83	1.83	0.30	1.22	0.30	0.61	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	20.30	4.79	2.26	2.54	0.56	0.00	0.28	0.56	0.85	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	7.73	2.38	0.59	0.00	0.89	0.59	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	15.62	2.08	1.04	1.04	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	10.49	1.42	0.85	1.70	0.43	0.14	0.14	0.28	0.14	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	11.60	1.20	0.40	0.40	0.80	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	6.81	0.00	1.05	0.52	0.52	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	26.96	6.71	4.60	2.11	2.48	0.50	0.37	0.37	0.37	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	36.50	3.69	4.35	2.39	1.74	0.65	0.00	0.87	0.22	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	26.50	4.76	3.30	2.44	1.47	1.10	0.00	0.12	0.37	0.12
Endothelial Cells - Vein, donor1	11267-116G7	4.55	1.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	3.49	0.70	0.00	0.00	0.00	0.00	0.00	0.70	0.00	1.40
Endothelial Cells - Vein, donor3	11416-118F3	7.07	1.10	0.79	1.57	0.94	0.00	0.00	0.00	0.31	0.00
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	0.00	0.00	0.00	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	4.95	0.00	1.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	3.57	0.00	3.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	7.09	0.49	0.24	0.00	0.24	0.24	0.73	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	2.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	37.36	7.39	2.46	4.52	2.46	0.41	1.23	1.23	1.64	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	37.45	3.50	3.07	0.33	3.50	1.64	1.20	0.11	0.44	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	111.15	5.53	4.88	2.71	2.49	0.76	0.22	0.11	0.22	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	34.08	9.22	6.19	1.70	4.85	2.18	0.61	0.73	0.97	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	81.88	27.16	24.16	5.73	19.79	10.37	5.60	1.91	3.96	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	41.03	7.49	5.59	1.90	2.43	1.69	1.69	1.16	0.63	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	153.61	13.96	26.61	4.22	9.75	2.90	4.48	1.32	1.32	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	61.12	11.96	7.64	1.99	3.99	2.99	1.00	1.33	1.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	45.36	5.90	6.80	1.81	0.45	0.91	0.45	0.45	0.91	0.00
Fibroblast - Cardiac, donor2	11345-117G4	5.31	1.52	0.00	0.00	0.00	0.00	0.76	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	5.52	0.79	0.63	1.10	0.16	0.47	0.32	0.16	0.16	0.00
Fibroblast - Cardiac, donor4	11452-119A3	142.16	37.59	36.98	5.46	16.67	10.61	7.27	3.33	4.24	0.00
Fibroblast - Cardiac, donor5	11456-119A7	24.11	7.11	9.64	1.90	5.71	1.65	0.63	0.25	1.40	0.13
Fibroblast - Cardiac, donor6	11460-119B2	54.27	7.58	9.40	2.12	3.64	1.21	0.91	1.06	0.61	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	54.00	2.81	4.42	3.89	1.47	0.94	1.21	0.94	0.54	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	81.54	4.75	5.61	2.16	1.73	0.86	3.88	1.29	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	14.65	0.00	1.46	0.00	0.00	0.00	0.00	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	25.60	1.85	2.54	3.23	0.69	0.46	1.15	0.46	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	105.66	23.58	18.49	4.07	5.60	5.09	5.26	3.22	1.36	0.00
Fibroblast - Dermal, donor1	11269-116G9	22.30	12.21	8.22	0.70	3.29	2.58	0.47	0.23	1.41	0.23
Fibroblast - Dermal, donor2	11346-117G5	11.32	5.66	4.72	0.00	1.42	0.00	0.00	0.47	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	30.34	8.46	7.01	1.57	3.26	1.57	2.90	0.73	0.73	0.00
Fibroblast - Dermal, donor4	11450-119A1	32.78	3.84	3.28	2.49	0.68	0.45	0.68	0.23	0.34	0.34
Fibroblast - Dermal, donor5	11454-119A5	43.96	3.66	4.36	2.44	3.49	1.05	1.22	0.87	1.05	0.17
Fibroblast - Dermal, donor6	11458-119A9	39.14	3.57	6.66	2.27	1.95	1.14	0.97	0.65	0.65	0.16
Fibroblast - Gingival, donor1	11237-116D4	42.69	14.16	10.41	2.92	6.25	2.08	1.46	0.83	0.62	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	61.57	9.17	10.48	2.62	2.62	0.79	1.83	0.00	0.26	0.52
Fibroblast - Gingival, donor2	11318-117D4	36.64	5.80	4.61	3.43	1.45	1.45	0.92	0.66	0.66	0.00
Fibroblast - Gingival, donor3	11394-118C8	61.78	13.92	13.63	3.77	4.45	2.13	4.06	1.26	0.87	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	29.09	14.54	9.35	3.12	8.31	2.08	0.00	0.00	3.12	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	34.18	8.11	6.34	2.64	3.00	1.76	1.41	0.88	2.11	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	35.39	8.26	5.61	2.34	2.49	0.62	0.47	0.62	0.62	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	35.16	6.76	7.84	2.03	3.65	1.22	1.62	0.41	0.68	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	121.74	5.29	6.70	3.88	2.82	1.76	1.76	1.41	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	80.00	11.41	11.70	1.61	3.51	2.63	2.19	1.90	0.29	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	35.32	8.73	6.27	0.82	3.00	0.55	0.55	0.82	1.23	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	66.58	13.71	10.75	1.54	6.47	3.40	0.77	0.88	1.32	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	84.23	11.74	11.59	7.78	2.79	1.03	3.08	2.64	1.17	0.15
Fibroblast - Lung, donor1	11270-116H1	17.67	1.36	2.72	1.36	1.36	0.00	1.36	0.00	0.00	2.72
Fibroblast - Lung, donor2	11347-117G6	61.18	17.91	7.46	1.49	5.97	0.00	1.49	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	27.86	7.60	5.49	2.32	1.90	1.27	1.48	0.84	1.06	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	18.33	1.67	0.83	0.83	0.00	0.00	1.67	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	12.59	0.00	2.80	1.40	1.40	2.80	0.00	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	3.36	0.28	0.28	0.00	0.28	0.00	0.28	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	12.99	1.22	1.22	0.00	0.41	0.00	3.25	0.81	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	29.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	38.21	6.01	5.43	2.72	4.07	1.36	1.16	1.36	0.78	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	45.96	9.40	5.46	3.94	2.43	1.82	1.67	0.61	1.06	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	37.94	12.55	8.87	2.14	6.12	1.53	3.98	1.22	0.92	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	40.45	8.40	8.78	1.91	3.82	1.14	1.53	0.76	1.53	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	45.63	17.28	15.66	1.62	8.10	6.21	2.16	0.54	2.43	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	31.20	7.07	6.15	1.97	3.60	0.93	3.13	0.93	1.16	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	14.70	4.20	2.43	0.55	1.33	0.66	0.11	0.11	0.11	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	12.39	0.81	0.41	1.22	0.61	0.00	0.61	0.61	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	17.37	2.00	1.34	0.67	0.67	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	34.79	7.91	6.33	2.77	1.58	1.58	1.19	1.19	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	77.00	8.73	18.65	2.58	10.52	2.38	3.57	1.79	1.98	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	27.53	12.61	10.12	1.24	6.04	1.60	2.66	1.60	0.71	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	41.19	17.93	13.80	0.39	4.93	3.35	2.76	2.17	0.39	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	55.96	4.81	12.64	2.41	5.42	1.20	3.01	2.11	0.90	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	34.00	9.93	10.47	1.30	5.07	2.81	4.10	0.97	1.62	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	45.55	9.36	18.22	1.77	9.11	3.29	3.29	3.04	1.01	0.00
Fibroblast - skin normal, donor1	11553-120C5	21.99	9.68	7.38	1.31	4.10	2.13	1.48	1.15	0.16	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	80.40	26.47	23.66	4.01	9.82	5.01	3.01	4.81	2.21	0.20
Fibroblast - skin normal, donor2	11561-120D4	25.72	7.84	8.64	2.01	5.22	1.61	0.50	0.80	0.50	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	103.37	13.30	18.13	7.56	6.35	3.63	9.07	2.42	1.51	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	41.17	16.73	12.76	2.40	6.05	3.40	6.05	1.49	0.83	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	55.05	13.16	17.27	3.08	5.81	2.91	5.81	2.56	0.85	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	43.02	6.90	14.45	2.63	12.48	2.30	1.97	2.63	1.31	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	23.22	11.72	11.61	1.07	8.10	3.30	0.53	1.07	0.53	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	25.47	8.94	5.74	0.67	3.37	1.86	1.35	1.01	0.34	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	14.58	7.21	4.55	1.25	3.29	1.41	0.47	0.31	0.47	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	132.96	0.00	0.00	0.00	22.16	0.00	0.00	0.00	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	21.79	0.00	0.00	3.49	2.61	0.00	1.74	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	12.14	2.95	1.73	1.04	1.04	1.21	0.52	0.52	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	12.75	1.82	1.04	1.82	1.04	0.52	0.52	1.56	0.00	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	8.94	1.53	1.02	0.77	1.02	0.00	0.51	0.26	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	17.61	0.00	0.77	0.77	0.00	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	18.50	0.64	0.00	0.64	0.00	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	22.25	0.29	0.29	2.28	0.00	0.00	0.00	0.00	0.00	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	54.60	0.28	0.83	11.86	0.00	0.00	0.00	0.00	0.55	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	81.97	1.60	0.68	8.45	0.23	0.23	0.00	0.00	0.23	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	37.05	0.20	0.20	3.17	0.00	0.20	0.00	0.20	0.20	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	53.13	0.26	0.00	8.19	0.00	0.00	0.00	0.00	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	115.13	1.63	2.28	12.39	0.33	0.98	0.00	0.33	0.98	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	14.59	0.00	0.00	2.21	0.44	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	28.41	1.27	1.13	2.40	0.42	0.14	0.00	0.14	0.00	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	51.10	1.72	2.34	4.56	0.86	0.37	0.12	0.49	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	22.56	1.34	1.61	2.42	0.54	0.00	0.00	0.00	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	42.62	2.85	1.86	4.34	0.62	0.25	0.50	0.74	0.25	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	48.73	1.25	1.38	5.54	1.38	0.42	0.83	0.97	0.42	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	25.62	1.22	0.81	2.85	0.61	0.00	0.41	0.41	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	58.19	5.70	3.42	5.93	2.51	0.68	0.00	1.37	0.00	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	67.14	3.74	4.36	3.99	1.74	1.00	0.75	0.37	0.25	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	74.53	4.81	3.93	8.96	1.75	1.31	0.44	0.22	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	49.05	4.43	2.07	5.02	1.48	0.30	0.00	1.48	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	51.82	3.50	1.91	4.29	2.38	0.48	0.16	0.64	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	59.88	2.90	2.68	7.60	1.34	1.12	1.12	0.67	0.45	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	35.69	1.41	2.22	3.02	1.01	0.00	0.00	0.40	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	36.30	2.37	2.37	3.39	1.36	0.17	0.34	0.34	0.34	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	63.76	7.54	4.08	5.05	4.34	0.89	0.62	1.42	0.62	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	46.72	2.39	1.98	6.14	2.29	0.52	0.42	0.10	0.42	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	46.11	3.24	3.59	4.61	1.71	0.17	0.34	0.85	0.51	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	33.31	3.43	2.66	3.43	1.88	0.77	0.44	0.22	0.33	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	43.51	4.99	3.66	3.66	2.25	0.83	1.08	1.00	0.33	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	41.04	4.29	3.68	2.86	2.25	0.61	0.82	1.23	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	33.22	3.51	0.83	4.75	1.24	0.62	0.21	0.83	0.62	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	42.89	2.54	1.38	4.38	1.15	0.35	0.23	0.46	0.46	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	31.19	1.67	2.17	3.00	0.83	0.00	0.50	0.67	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	41.88	0.66	2.87	5.95	0.22	0.22	0.66	0.22	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	38.37	1.11	2.71	3.94	0.86	0.61	0.00	0.61	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	29.99	2.11	1.62	2.43	0.97	0.97	0.32	0.16	0.00	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	41.69	3.21	3.53	6.74	0.96	0.32	0.00	0.64	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	27.10	1.80	1.42	2.18	0.85	0.09	0.47	0.28	0.00	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	23.57	2.06	1.42	2.69	0.63	0.32	0.00	0.47	0.32	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	28.28	3.04	3.65	1.52	1.22	0.00	0.61	0.30	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	23.83	1.99	1.67	2.72	1.25	0.10	0.52	0.21	0.10	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	29.64	4.39	2.20	3.95	1.10	0.44	0.22	0.66	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	27.49	1.96	1.68	3.09	1.68	0.28	0.56	0.28	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	27.96	2.59	2.41	1.67	1.20	0.19	0.19	0.46	0.19	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	21.66	2.14	1.34	1.34	1.87	0.27	0.80	0.53	0.53	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	17.75	4.44	3.06	1.38	1.07	0.15	0.31	0.15	0.00	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	22.15	2.85	2.85	0.91	1.55	0.52	0.13	0.13	0.13	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	30.09	1.36	1.90	2.98	0.81	0.54	0.54	0.54	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	33.18	3.87	1.66	2.03	2.58	0.00	0.18	0.37	0.37	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	39.26	2.41	3.95	2.41	1.10	0.66	0.22	0.22	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	51.57	4.96	1.98	6.94	2.98	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	33.51	3.56	4.09	1.85	1.85	0.79	0.92	0.40	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	35.91	3.63	2.42	2.62	1.61	1.01	1.21	0.61	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	72.69	3.05	2.80	7.12	0.76	0.25	0.00	0.51	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	8.56	0.20	0.00	1.00	0.00	0.00	0.00	0.00	0.00	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	19.11	0.15	0.15	1.23	0.00	0.00	0.00	0.00	0.00	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	15.34	0.00	0.41	1.84	0.00	0.00	0.41	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	17.52	0.31	0.94	0.00	0.00	0.00	0.31	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	15.82	0.00	0.28	0.85	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	17.06	0.46	0.46	0.92	0.00	0.00	0.00	0.00	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	59.40	2.47	0.00	9.90	0.00	0.00	0.00	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	38.29	0.77	2.71	2.71	0.77	0.00	0.39	0.00	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	72.20	0.00	4.81	3.21	0.00	0.00	0.00	0.00	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	60.86	1.74	3.48	6.96	1.74	0.00	1.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	44.92	2.93	2.28	3.91	0.65	1.30	0.00	0.33	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	46.12	2.88	3.29	1.65	1.24	1.24	1.24	0.41	0.82	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	69.98	3.33	3.33	3.33	3.33	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	61.80	2.52	2.24	1.40	0.56	0.28	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	61.12	2.94	2.29	2.94	0.98	0.65	0.00	0.98	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	49.49	3.36	2.52	5.03	0.84	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	55.98	3.50	3.50	2.54	1.27	0.95	0.00	0.32	0.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	38.38	2.04	1.70	2.72	1.70	0.34	0.34	0.00	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	41.76	2.09	0.00	6.26	0.00	0.00	0.00	4.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	41.23	2.86	1.72	5.15	1.72	0.57	0.00	0.00	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	36.11	2.66	0.59	1.48	0.59	0.30	0.30	0.59	0.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	44.05	0.00	1.69	6.78	1.69	0.00	1.69	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	38.52	2.49	1.66	1.66	1.66	0.83	0.41	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	33.83	2.30	2.53	2.30	0.69	0.46	0.23	0.00	0.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	89.56	5.27	5.27	5.27	0.00	0.00	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	31.14	4.23	1.15	3.46	1.54	0.00	0.38	0.00	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	39.44	1.96	1.30	2.93	1.96	0.65	0.00	0.00	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	64.88	5.35	2.68	4.01	2.01	0.67	0.67	0.67	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	44.69	1.54	1.54	7.32	0.77	0.77	0.00	0.77	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	53.41	4.79	3.77	6.50	3.08	1.03	2.05	1.03	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	136.66	0.00	0.00	2.48	2.48	0.00	2.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	54.26	1.42	0.94	4.25	1.42	0.47	0.94	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	38.62	4.22	4.83	4.83	1.21	0.00	0.00	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	54.43	1.53	3.56	3.56	0.51	0.00	0.51	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	43.87	1.99	2.79	3.19	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	49.34	3.45	1.97	5.43	2.47	0.49	0.49	1.48	0.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	59.02	4.72	1.18	5.90	4.72	0.00	1.18	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	41.42	2.92	3.50	3.50	0.00	0.58	0.58	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	63.64	3.51	4.39	6.58	3.51	0.44	0.44	0.88	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	43.23	2.54	2.54	4.24	3.39	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	38.80	2.39	0.00	2.39	1.19	1.19	0.60	1.79	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	32.03	2.91	2.91	2.43	2.43	0.00	0.49	0.49	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	13.70	4.57	3.42	0.00	9.13	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	14.14	6.65	5.41	1.25	2.49	2.49	0.42	1.25	1.25	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	12.37	0.00	1.12	0.00	2.25	0.00	3.37	0.00	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	16.18	7.61	6.03	2.54	3.81	1.59	0.32	0.00	0.63	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	19.22	7.94	6.68	0.84	2.51	1.25	0.84	0.84	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	2.32	0.70	0.23	0.35	0.46	0.00	0.00	0.00	0.12	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	2.87	0.84	0.84	0.51	0.51	0.17	0.17	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	2.05	0.00	0.46	0.00	0.68	0.00	0.23	0.00	0.23	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	2.73	0.66	0.44	0.33	0.33	0.00	0.22	0.33	0.11	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	3.87	0.43	0.00	0.00	0.64	0.00	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	3.88	0.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	2.74	0.37	0.12	0.37	0.62	0.12	0.00	0.25	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	2.23	0.34	0.00	0.34	0.34	0.00	0.17	0.17	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	1.28	0.64	0.00	0.32	0.00	0.00	0.00	0.00	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	11.19	0.00	1.12	1.12	1.12	0.56	0.56	0.00	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	2.16	0.00	0.00	0.00	0.00	0.00	0.00	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	15.86	2.64	2.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	16.58	1.41	1.76	1.76	1.06	0.35	0.35	0.35	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	15.26	0.73	0.00	1.45	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	11.71	1.40	1.75	1.40	0.70	0.35	0.17	0.17	0.00	0.35
Hepatocyte, donor1	11523-119I2	30.27	2.42	4.84	1.21	3.63	0.00	4.84	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	9.70	3.23	5.39	2.15	3.23	1.08	0.00	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	25.16	3.07	2.45	4.29	2.45	0.61	1.84	0.61	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	29.37	0.00	0.00	3.26	0.00	0.00	0.00	0.00	0.00	2.61
Intestinal epithelial cells (polarized), donor1	11246-116E4	29.71	3.85	2.27	2.27	1.75	1.22	0.52	0.70	0.35	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	11.11	2.74	1.65	1.23	0.55	0.27	0.27	0.27	0.14	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	1.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	0.00	0.00	0.00	1.62	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	1.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	0.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	0.00	0.00	0.00	1.61	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	0.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	0.94	0.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	1.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	0.00	1.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	1.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	1.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	0.00	0.00	0.00	0.31	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	1.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	1.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	0.00	0.00	0.00	3.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	1.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	2.25	2.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	1.07	0.00	0.00	0.00	0.00	1.07	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	0.00	2.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	0.00	0.00	2.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	2.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	9.63	0.73	0.65	0.57	0.41	0.16	0.00	0.16	0.00	0.00
Keratinocyte - epidermal, donor2	11349-117G8	0.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	4.83	0.38	0.47	0.76	0.09	0.00	0.00	0.09	0.00	0.00
Keratinocyte - oral, donor1	11251-116E9	24.18	3.29	2.61	2.61	0.68	0.00	2.16	1.02	0.11	0.00
Keratocytes, donor1	11527-119I6	24.07	3.44	1.72	2.41	2.41	0.34	1.03	0.34	0.34	0.00
Keratocytes, donor2	11607-120I5	23.44	0.00	2.34	0.00	1.17	0.00	2.34	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	41.69	4.74	5.34	1.78	0.79	0.59	2.57	1.19	1.19	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	61.54	2.20	0.00	8.79	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	8.63	3.24	3.24	0.00	1.08	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	38.06	7.61	5.07	4.73	2.08	0.81	0.23	0.46	0.35	0.35
Lens Epithelial Cells, donor3	11690-122I7	16.04	1.72	1.61	1.41	0.40	0.10	0.10	0.50	0.30	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	13.04	3.44	3.79	1.78	0.59	0.36	0.59	0.24	0.24	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	8.09	1.95	1.40	0.56	0.28	0.00	0.56	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	16.69	3.31	2.52	1.42	1.10	0.31	2.52	0.79	0.47	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	10.75	3.76	1.61	0.00	0.00	0.00	0.54	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	12.29	2.21	0.95	0.95	0.63	0.00	1.26	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	7.01	1.62	1.19	0.43	0.86	0.22	0.86	0.65	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	16.42	1.23	2.46	1.23	0.82	0.00	0.00	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	3.79	0.51	1.01	1.01	0.76	0.51	0.51	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	11.12	2.25	1.27	1.97	0.56	0.14	0.42	0.14	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	11.87	1.98	1.98	0.40	0.79	0.00	1.19	0.00	0.79	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	9.50	2.33	1.74	1.16	0.58	0.00	0.97	0.78	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	4.26	0.56	1.11	0.19	0.19	0.19	0.19	0.56	0.19	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	10.45	1.05	1.39	0.35	1.05	0.70	0.00	0.70	0.35	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	11.21	1.91	1.91	0.72	1.43	0.48	0.72	0.48	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	7.42	0.82	0.96	1.37	0.82	0.27	0.27	0.55	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	12.32	2.46	1.54	0.31	1.85	0.00	0.92	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	3.74	1.56	0.31	0.31	0.62	0.31	0.62	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	8.97	1.28	2.74	1.10	0.73	0.00	0.73	0.00	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	11.19	1.65	3.62	1.32	0.66	0.33	0.33	0.66	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	7.32	1.17	1.17	0.00	0.88	0.00	0.88	0.29	0.29	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	7.22	0.75	1.00	1.49	0.00	0.00	0.50	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	9.70	0.97	5.33	0.97	1.45	0.00	0.97	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	9.43	1.89	2.42	0.54	0.81	0.00	0.27	0.00	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	9.23	2.42	0.91	0.91	1.21	0.15	0.61	0.30	0.30	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	7.78	1.56	1.04	0.52	1.56	0.00	0.52	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	11.73	3.56	2.51	1.47	1.26	0.63	1.26	0.21	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	9.02	1.35	1.65	1.35	1.20	0.30	0.75	0.45	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	14.45	4.13	4.82	0.69	2.06	1.38	0.69	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	10.72	2.82	1.88	0.38	1.13	1.13	0.19	0.19	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	5.73	0.85	0.64	1.06	0.21	0.11	0.74	0.53	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	16.48	3.39	4.36	0.97	1.45	0.97	0.00	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	9.59	1.98	1.98	0.66	0.99	0.33	0.00	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	7.81	1.24	0.62	0.37	0.62	0.12	0.62	0.00	0.37	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	13.33	7.40	1.85	1.85	0.74	0.37	0.74	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	8.40	2.22	1.24	1.48	0.49	0.00	1.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	6.32	2.06	0.55	1.24	0.69	0.27	0.55	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	12.87	4.82	3.22	0.64	0.96	1.29	0.96	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	15.83	5.48	2.74	2.43	0.61	0.61	2.13	0.91	0.91	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	11.76	2.10	1.82	0.84	0.98	0.70	1.12	0.70	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	12.44	1.42	2.84	1.42	2.13	0.71	0.36	0.71	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	8.73	0.48	1.45	0.48	0.97	0.00	1.45	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	5.91	1.24	0.62	1.09	0.47	0.31	0.31	0.16	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	11.46	5.37	3.94	1.43	0.00	0.36	0.36	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	11.43	2.29	1.31	1.31	1.31	0.33	0.98	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	6.36	0.47	1.18	0.47	0.24	0.00	0.24	0.24	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	12.13	3.84	2.85	1.11	1.86	0.25	0.62	0.37	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	5.38	1.02	0.77	0.00	1.28	0.26	0.26	0.00	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	7.16	1.49	0.30	0.60	0.30	0.60	0.00	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	4.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	1.53	0.00	0.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	1.48	0.74	0.00	1.48	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	4.23	0.00	0.00	0.85	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	4.22	0.00	0.00	0.00	0.00	0.70	0.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	1.87	0.00	0.00	0.93	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	5.15	0.00	0.52	1.03	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	1.19	0.00	0.00	0.00	1.19	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	2.49	0.00	0.23	0.23	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	3.49	0.29	0.00	0.58	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	3.60	0.00	0.00	0.00	0.00	0.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	4.20	0.41	0.81	0.68	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	6.68	0.00	0.51	0.00	0.00	0.00	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	3.53	0.35	0.35	0.00	0.00	0.00	0.00	0.00	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	2.67	0.67	0.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	7.13	0.00	0.00	0.51	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	4.00	0.27	0.53	0.80	0.27	0.00	0.27	0.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	3.97	0.00	0.19	0.76	0.00	0.38	0.00	0.00	0.19	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	4.91	0.61	0.00	1.23	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	4.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	2.92	0.21	0.21	0.42	0.00	0.00	0.00	0.21	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	2.80	0.28	0.56	0.84	0.00	0.00	0.28	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	2.06	0.00	0.00	2.06	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	4.94	0.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	4.78	0.00	0.30	0.60	0.30	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	3.32	0.55	0.00	0.00	0.55	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	6.01	1.06	0.00	1.06	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	2.21	0.00	0.74	0.74	0.37	0.37	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	2.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	3.84	0.00	0.38	1.15	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	3.96	0.00	0.00	1.13	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	5.74	0.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	3.62	0.00	0.45	0.00	0.45	0.00	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	2.15	0.72	0.00	0.72	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	4.48	0.00	0.00	1.49	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	2.97	0.00	0.00	1.11	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	2.58	0.00	0.00	0.86	0.00	0.00	0.86	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	5.99	0.00	0.00	0.86	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	4.00	0.00	0.00	2.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	2.41	0.00	0.00	1.21	0.00	0.00	1.21	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	2.84	0.00	0.00	1.42	0.00	0.00	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	2.75	0.69	0.69	0.69	0.00	0.00	0.34	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	4.29	0.00	0.00	0.00	0.54	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	2.02	1.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	3.33	0.00	0.74	0.74	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	3.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	3.17	0.00	1.06	1.06	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	3.60	0.00	0.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	2.18	0.00	0.00	0.73	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	2.30	0.00	0.77	0.77	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	1.97	0.00	0.00	0.49	0.00	0.00	0.00	0.49	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	1.88	0.00	0.00	0.00	0.00	0.00	0.94	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	3.02	0.50	0.00	1.01	0.50	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	4.51	0.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	1.72	0.00	1.72	1.72	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	3.56	0.45	0.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	6.65	0.00	0.00	1.17	0.00	0.39	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	3.30	0.00	0.00	0.66	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	2.08	0.00	0.00	1.04	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	3.94	0.00	0.00	0.44	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	1.68	0.00	0.00	0.56	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	2.65	0.44	0.00	0.88	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	3.86	0.00	0.00	0.77	0.00	0.00	0.39	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	4.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	2.40	0.96	0.00	1.44	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	2.78	0.00	0.00	0.00	0.00	0.40	0.00	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	4.86	0.00	0.00	0.00	0.00	0.61	1.22	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	2.77	0.00	0.00	0.00	0.00	0.00	0.00	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	4.56	0.38	0.00	0.76	0.38	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	2.58	0.00	0.00	0.52	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	3.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	2.85	0.00	0.00	1.27	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	5.86	0.53	0.53	0.53	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	4.60	0.00	1.15	0.57	0.00	0.00	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	4.11	0.00	0.51	2.06	0.00	0.00	0.51	0.00	0.00	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	3.54	0.00	0.00	0.00	0.00	0.00	0.00	0.71	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	2.84	0.00	0.00	0.57	0.00	0.00	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	3.74	0.42	0.42	0.83	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	3.92	0.00	0.00	0.78	0.00	0.00	0.00	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	2.92	0.00	0.00	0.84	0.42	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	5.58	0.00	0.00	0.00	0.46	0.46	0.00	0.46	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	2.68	0.00	0.00	0.67	1.34	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	4.81	0.00	0.53	0.53	0.53	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	3.23	0.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	3.67	0.00	0.00	0.92	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	2.67	0.00	0.00	0.89	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	5.70	0.57	0.57	1.71	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	3.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	4.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	2.67	0.00	0.45	1.78	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	3.38	0.26	0.52	1.04	0.00	0.26	0.00	0.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	4.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	12.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	2.05	3.65	2.28	0.23	0.00	0.00	0.23	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	3.49	2.39	1.84	0.37	0.55	0.37	0.73	0.18	0.18	0.18
Macrophage - monocyte derived, donor3	11389-118C3	4.46	1.44	1.84	0.92	0.39	0.00	0.26	0.00	0.39	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	7.97	3.19	1.06	0.53	2.66	0.53	0.00	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	7.13	1.43	1.43	0.63	0.63	0.48	0.48	0.16	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	7.23	0.97	1.53	0.00	1.67	0.42	0.42	0.28	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	30.79	2.69	1.99	2.69	1.69	0.30	0.40	0.30	0.20	0.30
Mammary Epithelial Cell, donor2	11350-117G9	9.84	1.45	1.16	1.74	0.87	0.00	0.58	0.87	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	7.73	0.50	0.25	1.50	0.25	0.25	0.25	0.50	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, donor2	11565-120D8	5.05	1.19	2.08	1.78	0.00	0.30	0.30	0.00	0.00	0.59
Mast cell, donor3	11566-120D9	2.93	0.90	1.35	2.70	0.23	0.00	0.23	0.23	0.00	0.00
Mast cell, donor4	11567-120E1	2.48	0.35	0.71	0.71	0.00	0.00	0.00	0.00	0.00	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	0.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	0.58	0.00	0.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded, donor8	11941-126A6	0.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - dark, donor1	11502-119F8	10.94	4.97	3.28	2.19	1.39	0.50	0.20	0.20	0.10	0.00
Melanocyte - dark, donor2	11582-120F7	24.23	4.15	5.54	1.04	0.00	0.00	1.73	0.35	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	9.20	3.48	2.83	1.16	1.45	0.29	0.29	0.07	0.14	0.07
Melanocyte - light, donor1	11274-116H5	8.70	1.41	0.71	1.41	0.94	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	4.78	0.00	0.00	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	6.94	2.60	1.73	0.00	1.73	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	7.81	1.77	1.46	0.83	0.62	0.00	0.10	0.52	0.10	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	20.17	4.30	2.69	1.08	0.54	0.27	0.00	0.54	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	13.93	3.21	2.95	1.61	0.27	0.27	0.27	0.27	0.00	0.00
Meningeal Cells, donor1	11493-119E8	20.10	1.98	1.74	1.98	1.24	0.37	2.48	0.62	0.25	0.12
Meningeal Cells, donor2	11573-120E7	26.41	1.76	2.20	2.64	1.32	0.00	1.76	0.88	0.00	0.00
Meningeal Cells, donor3	11654-122E7	20.21	4.56	2.93	1.79	1.30	0.16	0.33	0.49	0.24	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	32.51	9.12	5.70	2.28	2.57	0.86	0.86	0.57	1.43	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	16.91	4.23	1.41	0.91	1.21	0.30	0.50	0.10	0.20	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	28.91	2.63	2.63	1.31	2.63	0.00	6.57	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	15.70	6.54	1.31	0.00	0.00	0.00	0.00	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	12.20	5.02	1.44	0.72	0.00	0.72	0.00	0.00	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	23.51	6.35	5.72	1.27	2.54	1.06	1.48	0.42	1.48	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	19.10	9.55	3.52	1.51	5.53	0.50	0.50	1.01	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	18.02	2.20	1.54	0.66	1.32	0.44	0.22	0.00	0.22	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	17.53	2.19	2.92	1.46	0.73	1.46	0.73	0.73	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	18.01	0.41	1.64	1.23	0.00	0.00	0.41	0.41	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	47.92	6.51	7.76	2.22	2.08	1.39	2.63	1.39	0.14	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	13.01	1.49	0.37	0.74	0.37	0.00	0.37	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	34.21	5.66	4.08	2.11	2.24	0.53	1.84	1.18	0.26	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	5.34	0.59	0.89	0.00	0.00	0.00	0.59	0.89	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	6.40	0.64	0.00	0.64	0.00	0.00	0.64	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	11.70	5.32	3.90	0.35	3.19	1.06	1.06	0.35	0.71	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	21.58	4.38	1.56	0.94	0.63	1.25	1.88	0.94	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	10.89	0.73	0.00	0.73	0.00	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	12.20	2.39	2.39	1.86	1.06	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	10.51	0.00	1.50	0.00	0.50	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	5.85	0.79	0.58	0.87	0.14	0.00	0.22	0.07	0.00	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	21.61	4.05	2.70	4.05	1.35	1.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	7.88	5.91	4.19	1.48	1.72	1.48	1.23	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	8.83	4.12	3.83	0.88	1.77	0.88	0.88	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	3.46	6.91	0.00	0.00	3.46	6.91	0.00	0.00	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	4.03	3.72	4.34	0.93	0.93	0.62	1.55	0.00	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	3.73	2.90	5.39	0.41	0.41	0.62	0.21	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	18.53	2.32	2.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	5.01	2.50	3.50	1.50	1.00	0.75	1.00	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	8.38	3.72	1.86	0.93	0.93	0.47	2.33	0.47	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	4.67	2.24	3.05	0.20	0.41	0.41	1.22	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	6.73	4.36	3.56	0.40	0.79	1.19	0.79	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	4.42	3.54	0.00	0.00	0.88	0.00	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	1.90	2.28	2.28	0.00	0.38	0.38	0.76	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	7.90	0.00	0.00	0.00	1.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	6.15	3.18	4.67	1.27	1.06	0.85	0.42	0.21	0.64	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	6.45	2.76	3.68	0.92	0.00	0.00	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	3.28	4.47	2.38	0.60	0.89	0.60	0.30	0.00	0.89	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	16.77	3.35	3.35	1.68	0.00	0.00	0.00	0.00	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	6.27	3.51	5.02	0.75	0.75	0.25	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	3.33	3.09	2.38	0.48	0.71	0.48	0.95	0.24	0.24	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.21	1.11	1.66	0.00	1.11	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	4.14	4.84	3.22	0.46	0.69	0.00	0.23	0.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	3.16	2.94	1.68	0.21	0.63	0.42	0.63	0.21	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	3.67	2.45	3.87	0.82	1.22	0.61	0.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	3.65	3.22	2.57	0.21	0.86	0.43	1.29	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	7.11	4.00	2.89	0.22	0.44	0.44	0.22	0.22	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	3.07	2.19	1.53	0.22	0.88	0.44	1.31	0.22	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	5.07	3.55	2.03	0.51	1.52	1.01	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	1.66	4.97	0.00	0.00	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	2.45	2.45	2.45	0.54	0.82	0.00	0.54	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	5.59	4.12	3.82	0.00	1.18	0.29	0.29	0.00	0.59	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	3.27	4.36	0.00	1.09	2.18	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	0.96	3.36	3.84	0.00	0.96	0.48	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	4.80	3.60	4.00	0.40	2.80	1.20	0.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	2.74	5.48	1.37	0.00	0.00	0.00	0.00	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	1.50	3.00	4.00	0.00	4.00	0.50	0.00	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	6.12	2.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	1.75	2.63	2.19	0.44	1.75	1.31	0.00	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	7.73	2.21	5.52	0.00	1.10	1.10	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	5.12	1.28	1.28	0.64	0.64	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	2.98	2.23	2.48	0.00	1.49	0.50	0.50	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	3.48	3.48	2.78	0.00	4.87	0.70	0.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	0.00	2.21	0.00	4.42	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	1.37	3.42	1.71	0.00	1.03	1.03	0.00	0.00	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	3.06	3.50	4.81	0.44	0.44	1.31	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	2.84	1.42	1.42	0.36	0.36	1.07	0.00	0.00	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	2.52	1.68	2.81	0.28	2.52	0.56	0.28	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	0.83	4.99	6.23	1.25	2.08	1.66	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	3.50	2.33	1.17	0.00	1.17	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	1.81	3.32	3.02	0.00	0.30	1.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	1.25	2.92	5.43	0.00	1.25	0.83	1.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	7.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	0.92	1.85	6.46	0.00	0.00	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	1.71	5.69	4.55	0.57	3.98	1.71	0.00	0.00	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	2.63	1.93	2.76	0.28	1.24	0.00	0.00	0.00	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	1.55	2.07	1.81	0.52	1.04	0.78	0.52	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	2.14	6.86	2.14	0.00	3.43	0.00	0.43	0.00	0.86	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	3.81	2.54	1.91	0.64	0.64	0.00	0.00	0.00	0.64	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	1.60	2.14	2.94	0.00	2.14	0.53	0.53	0.27	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	1.50	3.29	2.69	0.60	1.50	0.30	0.30	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	1.70	1.41	1.13	0.42	0.14	0.28	0.42	0.00	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	0.64	3.19	1.91	0.00	0.64	0.96	0.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	1.99	5.75	3.10	0.22	1.99	0.44	0.22	0.22	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	3.41	3.41	1.52	0.00	0.00	0.00	0.00	0.00	0.38	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	1.99	1.99	2.27	0.28	1.42	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	1.72	6.15	3.20	0.00	1.72	0.49	0.74	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	0.00	1.96	1.96	1.96	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	1.76	2.94	3.23	0.29	0.29	0.00	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	0.86	1.73	2.02	0.29	0.00	0.29	0.58	0.29	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	2.47	2.47	1.65	0.41	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	2.38	4.17	2.08	0.60	0.60	0.00	0.30	0.00	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	3.56	1.78	1.78	0.00	0.00	0.00	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	2.63	3.29	2.96	0.33	0.00	0.00	0.00	0.00	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	2.10	0.00	0.00	0.00	0.00	1.05	1.05	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	3.76	2.77	2.77	0.20	0.00	0.40	0.20	0.40	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	11.18	1.86	6.52	0.00	0.93	0.00	0.93	1.86	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	5.63	4.13	2.25	1.50	1.13	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	2.93	2.40	2.40	1.60	0.53	0.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	2.26	1.58	2.04	0.45	0.23	0.00	0.23	0.11	0.00	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	2.95	2.95	1.47	0.00	0.74	0.74	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	4.76	2.93	1.83	0.37	0.37	0.73	0.73	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	4.67	0.00	6.22	0.00	0.00	0.00	1.56	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	1.60	3.21	3.74	0.53	0.00	0.53	1.07	1.60	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	0.00	0.00	0.00	0.00	0.00	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	4.04	2.02	2.02	1.01	0.00	0.00	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	3.79	2.11	5.48	0.42	0.84	0.00	0.42	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	14.98	2.72	4.09	1.36	1.36	0.00	1.36	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	4.45	1.27	0.64	0.00	0.64	0.64	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	2.43	5.67	3.24	1.62	1.62	0.00	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	10.57	9.06	3.02	1.51	1.51	0.00	3.02	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	74.23	11.42	0.00	0.00	17.13	5.71	0.00	5.71	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	55.46	6.52	3.26	0.00	16.31	3.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	47.52	9.50	9.50	0.00	9.50	0.00	0.00	0.00	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	100.39	25.10	0.00	0.00	12.55	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	34.47	10.77	7.76	1.94	6.03	2.59	1.08	1.51	1.51	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	58.01	10.45	8.88	2.61	5.23	1.57	1.57	0.00	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	133.50	7.34	6.01	5.34	3.34	1.33	0.00	0.00	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	174.04	9.18	10.43	8.35	1.67	2.09	0.42	0.00	0.83	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	115.61	15.02	7.80	7.04	3.80	4.37	1.52	0.76	0.76	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	100.54	15.96	15.96	7.98	0.00	4.79	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	147.55	5.44	8.84	5.44	2.04	1.36	1.36	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	14.70	33.08	3.68	5.51	9.19	1.84	1.84	0.00	5.51	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	162.39	5.86	11.72	6.28	3.77	1.67	0.42	0.42	2.09	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	156.66	13.48	15.11	4.65	3.72	2.32	0.23	0.46	0.46	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	156.19	5.40	10.00	5.94	1.62	1.62	0.27	0.54	0.81	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	71.69	11.77	12.82	4.84	4.41	1.68	0.42	0.42	1.05	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	77.94	100.21	0.00	0.00	0.00	22.27	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	68.99	4.96	9.43	1.99	1.99	2.98	0.50	0.50	1.99	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	118.82	12.99	12.18	4.60	5.41	0.81	1.62	1.62	0.81	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	158.00	9.07	17.23	4.31	3.40	2.04	1.36	0.23	0.68	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	141.09	7.68	9.47	3.76	1.80	1.31	0.98	0.49	0.82	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	50.48	12.58	14.40	2.00	3.46	2.55	1.64	0.91	1.46	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	152.24	10.61	16.44	2.12	5.83	3.18	2.12	1.59	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	76.84	9.60	13.21	1.20	1.80	3.60	0.00	0.00	2.40	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	97.80	17.39	13.46	3.61	7.22	2.63	3.61	2.30	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	150.91	9.76	16.59	3.58	3.25	2.60	0.98	0.81	1.46	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	59.44	13.58	12.88	2.29	4.76	2.82	0.71	0.35	1.76	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	127.28	13.36	12.66	4.92	6.33	3.52	0.70	0.70	1.41	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	114.01	12.41	20.69	4.14	5.06	5.06	0.92	0.00	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	121.79	7.07	11.89	6.43	3.86	2.89	0.64	1.93	0.96	1.61
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	94.15	23.11	14.49	3.10	11.38	7.24	0.69	0.69	1.03	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	50.57	35.40	12.64	5.06	7.59	7.59	2.53	0.00	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	65.72	13.14	12.70	1.34	3.79	2.67	1.11	0.45	0.89	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	135.91	8.47	12.28	9.74	2.96	2.12	1.27	0.00	1.27	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	77.38	16.14	17.80	2.85	4.75	3.56	0.95	0.24	0.24	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	125.77	11.59	10.73	5.15	2.58	2.58	2.15	0.00	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	36.11	117.36	36.11	9.03	0.00	9.03	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	124.96	7.00	8.00	6.33	2.67	2.00	1.67	1.00	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	77.55	4.06	9.92	2.71	1.35	1.80	0.45	0.90	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	89.68	5.56	9.13	5.95	2.78	3.17	1.59	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	78.01	8.36	17.64	0.93	0.93	4.64	0.00	0.93	0.93	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	110.48	7.57	7.57	7.19	3.03	3.78	1.51	0.76	0.00	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	99.07	2.61	6.52	3.58	1.30	1.63	0.98	0.65	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	126.38	6.54	7.84	5.67	0.00	0.87	1.31	0.44	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	58.80	7.69	8.14	2.26	0.90	1.36	0.45	0.45	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	107.59	0.88	4.41	1.76	0.00	0.88	0.00	0.88	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	91.75	14.63	25.93	3.99	4.65	1.99	1.33	0.00	1.33	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	115.58	7.44	9.92	7.94	2.98	3.47	2.98	0.00	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	133.61	3.45	5.36	4.98	1.91	0.77	0.38	0.38	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	98.60	13.01	14.21	7.56	6.35	3.02	2.12	1.51	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	38.90	3.76	3.09	0.44	2.21	0.66	0.66	0.22	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	84.71	8.13	10.16	2.03	2.03	0.68	0.68	0.00	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	35.77	91.97	15.33	0.00	10.22	5.11	0.00	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	100.60	7.93	7.93	4.88	3.05	3.66	0.61	0.00	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	117.40	3.46	4.41	2.83	1.89	0.63	1.89	0.31	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	181.89	6.66	10.90	8.17	2.12	1.21	1.21	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	76.74	3.16	1.58	5.54	3.96	0.00	0.00	1.58	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	95.23	17.00	10.20	4.53	3.40	6.80	2.27	0.00	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	25.29	65.75	25.29	5.06	25.29	5.06	0.00	0.00	10.12	0.00
Myoblast, donor1	11241-116D8	20.62	11.30	7.83	0.62	6.83	3.60	0.25	0.25	0.99	0.12
Myoblast, donor2	11322-117D8	41.43	9.78	11.32	2.49	4.41	1.92	2.69	1.34	1.53	0.38
Myoblast, donor3	11398-118D3	26.40	6.89	7.57	2.86	5.04	1.35	1.85	0.67	0.50	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	23.06	3.79	2.33	1.31	1.31	0.29	0.15	0.88	0.29	1.46
Natural Killer Cells, donor1	11230-116C6	30.44	8.92	2.46	3.38	3.38	0.62	0.92	2.46	0.00	5.23
Natural Killer Cells, donor2	11311-117C6	28.65	3.62	3.32	2.71	1.51	0.60	0.00	1.51	0.30	5.13
Natural Killer Cells, donor3	11387-118C1	30.00	5.52	3.87	5.15	1.47	0.74	0.55	1.10	0.37	6.07
Neural stem cells, donor1	11275-116H6	253.69	21.41	19.96	9.07	9.44	3.63	2.18	1.81	1.81	0.73
Neural stem cells, donor2	11352-117H2	148.27	7.70	7.70	17.33	1.93	1.93	3.85	3.85	0.00	0.00
Neurons, donor1	11494-119E9	47.79	9.10	11.38	2.28	2.28	0.00	1.14	0.00	1.14	0.00
Neurons, donor2	11574-120E8	57.90	5.72	2.64	5.50	2.64	0.88	0.66	0.00	0.22	0.22
Neurons, donor3	11655-122E8	88.79	4.11	9.04	3.29	4.11	0.82	2.47	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	0.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	1.22	0.00	0.00	1.22	0.00	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	42.51	17.34	17.81	3.21	5.34	2.97	2.61	1.07	2.49	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	35.49	5.21	6.84	2.60	0.65	0.65	0.65	0.65	0.65	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	45.53	8.62	14.84	2.61	4.21	2.21	0.80	0.60	0.60	0.00
Olfactory epithelial cells, donor1	11933-125I7	35.51	7.57	5.51	1.24	2.89	1.10	0.55	0.55	0.28	0.28
Olfactory epithelial cells, donor2	11934-125I8	40.24	7.53	5.36	1.59	4.78	1.01	0.43	0.29	1.45	0.14
Olfactory epithelial cells, donor3	11935-125I9	48.24	7.49	6.47	1.82	3.29	1.14	1.25	0.45	0.57	0.11
Olfactory epithelial cells, donor4	11936-126A1	84.54	10.32	7.89	3.80	3.41	1.46	1.17	0.78	0.58	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	13.84	2.41	0.60	7.22	2.41	1.20	0.00	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	45.09	6.81	6.38	1.70	2.77	2.13	2.34	1.28	0.64	0.64
Osteoblast - differentiated, donor2	11353-117H3	35.44	0.00	1.14	2.29	1.14	0.00	1.14	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	27.93	8.07	4.97	1.86	1.86	1.86	1.24	1.24	1.24	0.00
Osteoblast, donor1	11277-116H8	22.08	0.98	1.17	0.98	1.56	0.39	0.59	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	39.33	4.92	6.32	3.51	4.21	2.11	0.00	0.70	0.70	0.00
Osteoblast, donor3	11426-118G4	38.21	7.46	7.29	1.96	2.13	2.13	0.53	0.89	0.53	0.00
Pancreatic stromal cells, donor1	11249-116E7	34.62	20.30	11.71	2.44	6.65	2.61	1.85	1.52	1.43	0.08
Pericytes, donor1	11491-119E6	19.03	1.22	1.00	1.45	0.22	0.00	0.33	0.11	0.00	0.00
Pericytes, donor2	11571-120E5	25.13	0.45	0.45	1.36	0.23	0.00	0.00	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	9.97	0.81	0.81	1.02	0.81	0.41	0.81	0.61	0.00	0.00
Perineurial Cells, donor1	11499-119F5	39.22	7.23	5.43	3.39	2.37	1.02	0.79	0.23	0.23	0.45
Perineurial Cells, donor2	11579-120F4	25.86	7.82	4.32	1.66	3.40	2.12	2.48	0.92	0.64	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	40.16	9.56	6.06	6.37	2.87	0.96	1.91	0.96	0.00	3.19
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	29.87	7.10	3.92	4.16	1.22	0.73	0.73	1.22	0.98	1.96
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	28.47	5.69	3.62	4.92	1.81	0.65	1.29	0.78	0.00	2.33
Placental Epithelial Cells, donor1	11278-116H9	17.70	1.91	2.15	2.39	1.67	0.48	0.00	0.72	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	14.42	0.00	2.22	0.00	0.00	0.00	0.00	0.00	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	15.90	0.98	1.77	0.59	0.98	0.00	0.00	0.00	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	12.97	1.90	1.27	0.95	0.63	1.27	0.32	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	22.89	4.69	1.50	0.19	2.63	1.50	0.94	0.94	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	27.80	7.05	7.57	3.39	4.31	1.17	2.74	0.78	0.78	0.13
Preadipocyte - breast, donor2	11328-117E5	19.14	4.50	2.25	0.68	1.80	0.23	2.03	0.45	0.23	0.00
Preadipocyte - omental, donor1	11468-119C1	26.96	5.97	5.75	1.81	3.62	1.17	0.75	0.53	0.75	0.32
Preadipocyte - omental, donor2	11329-117E6	32.74	7.42	3.93	3.93	4.80	1.31	0.87	0.00	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	22.20	4.01	3.29	1.58	2.58	1.15	0.57	0.29	0.43	0.14
Preadipocyte - perirenal, donor1	11469-119C2	11.81	0.98	1.97	1.97	0.00	0.00	3.94	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	9.52	2.46	1.54	1.23	0.61	0.31	0.31	0.61	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	12.04	4.07	3.72	0.71	2.30	0.53	0.35	0.18	0.53	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	16.01	4.60	2.55	0.85	0.85	0.51	0.68	0.51	0.51	0.00
Preadipocyte - visceral, donor1	11280-116I2	26.73	12.48	8.10	1.58	4.66	1.96	0.84	0.47	0.84	0.00
Preadipocyte - visceral, donor2	11357-117H7	21.17	4.60	4.14	1.84	2.30	0.92	1.38	0.46	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	18.91	4.18	4.18	1.25	1.99	1.46	0.63	0.73	0.42	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	37.26	2.26	2.56	3.02	1.51	0.15	1.06	0.30	0.15	0.00
Prostate Epithelial Cells, donor2	11331-117E8	3.66	0.41	0.41	0.95	0.27	0.00	0.00	0.14	0.00	0.00
Prostate Epithelial Cells, donor3	11404-118D9	25.17	0.98	0.80	2.51	0.43	0.12	0.31	0.12	0.06	0.00
Prostate Stromal Cells, donor1	11254-116F3	20.96	8.77	6.83	1.71	3.99	1.37	1.48	0.23	0.91	0.23
Prostate Stromal Cells, donor2	11332-117E9	38.37	9.14	6.45	1.97	3.77	2.33	1.61	0.72	1.26	0.36
Prostate Stromal Cells, donor3	11405-118E1	25.55	8.65	8.97	1.56	4.28	2.29	1.46	1.25	0.83	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	11.31	0.73	0.36	1.46	0.36	0.36	0.36	0.36	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	18.16	3.95	2.43	1.94	1.94	0.42	0.28	0.49	0.07	0.00
Renal Epithelial Cells, donor1	11517-119H5	7.61	1.01	0.51	1.52	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	8.54	0.71	0.71	0.71	0.71	0.00	0.00	0.00	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	21.81	2.86	1.91	3.28	0.74	0.32	0.32	0.85	0.11	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	4.77	0.00	2.04	0.00	0.68	0.68	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	9.70	1.08	1.48	0.81	0.54	0.13	0.00	0.00	0.27	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	15.10	2.22	2.00	1.11	0.67	0.67	0.00	0.67	0.00	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	10.65	0.00	0.67	0.67	0.00	0.00	0.00	0.00	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	8.58	0.66	0.66	0.66	0.22	0.00	0.44	0.22	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	15.67	1.88	0.00	0.00	0.63	0.00	0.63	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	8.32	0.83	0.83	0.55	0.28	0.00	0.00	0.28	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	8.86	2.15	0.54	1.34	1.61	0.54	0.54	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	5.06	2.53	0.84	0.84	1.27	0.42	0.42	0.42	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	7.14	0.96	0.77	0.39	0.19	0.19	0.00	0.58	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	19.19	2.59	1.56	2.07	3.11	0.26	0.26	1.04	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	10.52	0.28	1.14	0.28	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	3.09	3.09	1.03	1.03	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	19.07	3.76	2.26	1.76	1.51	0.00	0.75	0.50	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	34.61	6.41	3.07	5.88	3.88	1.20	2.54	0.53	0.13	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	108.10	20.55	11.61	5.36	3.57	0.89	0.89	0.00	0.00	2.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	72.65	18.16	8.81	5.50	7.15	1.65	3.85	0.55	0.55	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	85.27	10.44	6.96	4.06	2.32	1.16	0.58	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	56.43	5.59	7.80	3.51	4.03	1.04	0.26	0.52	0.65	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	65.44	7.85	5.46	4.77	3.28	2.48	0.40	0.79	0.70	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	69.38	14.72	9.70	4.68	6.25	3.35	0.78	1.23	0.67	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	45.90	6.45	7.57	3.72	5.09	1.98	0.74	0.74	0.37	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	56.76	6.99	5.24	5.13	3.85	2.10	0.93	0.93	1.28	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	79.74	11.79	8.78	3.93	3.47	1.39	0.92	1.39	1.39	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	57.91	4.65	6.30	3.29	3.15	0.96	1.10	0.14	0.27	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	60.36	8.32	6.96	3.48	4.69	1.36	0.61	0.91	0.15	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	80.46	15.05	10.75	8.78	5.38	1.97	1.25	1.61	1.08	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	52.07	3.16	6.03	3.16	3.44	1.00	0.43	1.15	0.14	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	48.08	8.91	5.04	5.90	3.22	1.18	0.54	0.32	0.75	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	63.95	10.62	4.65	3.98	3.98	1.11	0.00	0.44	1.55	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	60.99	2.29	6.88	2.87	2.87	0.38	0.57	0.38	0.19	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	59.72	9.04	5.50	4.94	2.89	1.49	0.65	1.12	0.75	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	78.92	15.41	6.76	5.07	6.01	1.88	0.94	1.88	0.94	1.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	66.22	4.78	5.04	3.72	2.79	1.46	0.40	0.40	0.80	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	51.20	8.47	5.84	5.26	3.80	2.34	0.49	0.68	0.88	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	63.02	8.98	8.02	4.20	5.16	1.53	1.53	0.95	0.95	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	55.96	5.23	6.41	4.06	3.10	1.28	0.75	0.53	0.75	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	61.67	7.29	5.05	4.20	3.92	1.68	1.12	1.12	0.56	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	70.24	7.86	6.84	4.61	4.44	2.22	1.03	1.03	0.68	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	68.37	4.92	6.20	4.92	4.19	0.73	0.91	0.55	0.91	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	51.38	6.25	4.54	6.62	2.82	1.59	0.61	0.61	0.86	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	64.07	11.42	6.04	4.43	3.09	2.69	0.67	0.94	0.67	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	43.64	3.07	5.19	2.36	2.83	1.18	0.47	0.24	0.24	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	49.40	7.34	2.98	4.76	3.37	1.59	0.79	0.79	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	69.69	10.76	7.72	6.08	4.44	3.27	0.47	0.94	0.70	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	48.31	2.90	4.35	2.49	3.32	0.83	0.62	0.21	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	58.18	7.74	5.97	5.75	4.87	1.55	0.44	1.55	0.22	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	67.26	9.61	8.36	5.01	3.97	2.09	1.25	0.63	0.42	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	53.83	5.25	6.19	2.83	4.17	1.62	1.21	1.08	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	68.63	9.03	5.45	6.64	3.07	1.36	0.51	0.51	0.34	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	73.84	10.22	8.10	3.66	2.89	1.35	0.96	0.77	0.39	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	61.55	3.61	4.64	2.75	2.75	0.69	0.69	1.03	0.52	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	79.42	7.68	5.90	4.94	3.29	1.51	0.69	0.82	0.55	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	74.20	12.31	6.57	4.43	4.10	2.79	0.82	0.66	1.31	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	61.01	2.56	5.62	3.07	2.39	0.85	1.02	0.68	0.51	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	45.87	7.99	5.33	3.11	3.26	0.30	0.59	0.59	0.15	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	75.17	10.66	5.60	5.33	4.00	1.60	0.80	0.80	0.53	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	86.42	7.47	10.51	6.08	5.39	2.21	2.07	0.14	1.11	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	40.48	6.67	4.05	5.95	5.00	1.19	0.95	0.00	0.71	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	84.24	7.46	6.45	6.65	4.64	1.41	0.60	1.01	0.20	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	56.41	3.96	4.52	3.86	4.24	1.32	0.38	0.57	0.09	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	102.01	14.32	8.38	5.59	8.73	2.79	0.35	2.10	1.05	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	140.83	17.83	13.00	6.04	7.86	4.23	1.81	1.51	1.81	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	52.01	4.53	5.14	5.02	4.16	0.86	1.35	0.86	0.37	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	166.80	39.74	21.98	17.61	14.70	6.11	3.49	2.18	2.62	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	102.82	17.64	11.56	9.13	3.04	3.04	0.61	0.61	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	56.66	7.53	4.52	3.92	3.62	0.60	0.30	0.60	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	96.36	10.18	6.11	9.05	6.79	1.36	1.36	0.68	0.90	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	88.96	8.99	8.99	10.48	4.79	1.80	1.20	0.60	0.30	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	83.60	9.09	10.04	7.91	7.32	2.24	1.77	0.94	0.71	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	105.44	15.15	10.67	13.87	4.91	1.92	1.92	1.49	2.35	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	97.36	8.41	9.62	10.82	5.41	3.00	0.60	0.60	0.00	0.00
Schwann Cells, donor1	11498-119F4	11.66	0.38	0.94	0.94	1.13	0.19	0.19	0.00	0.19	0.00
Schwann Cells, donor2	11578-120F3	17.01	3.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.40
Schwann Cells, donor3	11659-122F3	33.74	3.51	2.85	0.88	1.10	0.44	0.44	0.00	0.66	0.00
Sebocyte, donor1	11220-116B5	9.31	2.19	0.00	1.10	0.55	0.00	1.10	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	9.19	1.38	0.92	0.00	0.00	0.00	0.46	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	13.19	2.68	1.03	0.82	0.00	0.41	0.21	0.41	0.00	0.00
Sertoli Cells, donor1	11255-116F4	26.51	9.94	9.94	1.66	4.97	1.66	3.31	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	104.50	16.95	5.65	5.65	5.65	0.00	2.82	2.82	2.82	2.82
Skeletal Muscle Cells, donor1	11281-116I3	36.33	5.19	3.26	2.38	1.76	0.44	1.14	0.53	0.35	0.09
Skeletal Muscle Cells, donor2	11358-117H8	32.53	2.89	2.89	1.45	0.72	0.72	1.45	0.00	1.45	0.00
Skeletal Muscle Cells, donor3	11430-118G8	21.74	0.84	1.67	5.85	0.00	0.84	0.00	0.00	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	35.66	6.60	8.17	3.14	2.83	1.73	1.57	1.73	0.31	0.16
Skeletal Muscle Cells, donor5	11455-119A6	44.74	6.84	8.92	2.68	2.53	1.19	2.68	0.89	0.74	0.15
Skeletal Muscle Cells, donor6	11459-119B1	29.86	3.08	4.16	3.08	1.85	0.62	0.15	0.00	0.62	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	43.22	9.45	6.43	2.02	1.51	0.88	6.93	2.27	0.38	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	55.36	7.99	6.56	3.57	1.43	1.57	4.14	1.28	0.57	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	30.85	7.84	5.56	2.48	2.28	1.19	1.49	0.20	0.79	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	36.48	4.47	3.62	2.02	2.27	0.67	1.01	0.42	0.08	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	20.27	0.00	2.17	0.00	2.17	0.00	0.00	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	16.37	2.89	3.58	1.10	1.93	0.28	0.28	0.28	0.41	0.14
Skin - palm, donor1	10286-104F7	26.86	5.37	13.43	5.37	2.69	2.69	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	9.37	0.43	0.72	1.01	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	84.24	1.64	0.82	1.64	1.64	0.00	1.64	1.64	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	12.46	0.00	0.39	0.65	0.26	0.00	0.00	0.00	0.00	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	11.26	0.70	0.56	1.39	0.97	0.14	0.56	0.28	0.00	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	11.25	1.41	0.42	1.27	0.28	0.14	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	43.77	1.69	1.48	5.07	1.27	0.63	1.48	1.27	0.00	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	27.88	0.52	0.60	2.70	0.45	0.15	0.75	0.75	0.00	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	27.77	1.54	2.16	0.62	2.16	0.93	0.62	0.31	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	42.02	2.67	9.78	2.22	4.45	1.56	2.22	0.22	0.67	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	22.34	4.70	1.76	1.18	1.18	0.59	0.59	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	17.90	6.41	6.19	0.88	1.99	0.88	0.66	0.44	0.22	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	9.84	2.36	3.54	1.58	2.76	0.79	0.39	0.39	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	23.95	3.09	2.32	2.32	0.77	0.77	2.32	1.55	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	43.03	4.00	5.00	5.00	2.00	0.00	2.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	15.04	2.66	1.06	0.53	1.60	0.40	0.53	0.40	0.40	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	22.39	6.87	6.65	0.89	2.22	1.55	0.44	0.66	0.44	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	30.98	4.87	5.12	1.79	3.20	2.05	1.28	0.51	0.51	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	37.44	11.72	10.09	2.28	3.58	0.65	0.98	1.95	0.33	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	40.75	15.06	9.75	4.73	5.61	2.95	1.77	2.07	0.00	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	19.50	5.13	4.27	1.42	2.56	1.28	0.71	0.57	0.14	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	9.92	2.77	1.95	0.16	0.98	0.65	0.16	0.65	0.16	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	76.41	17.66	18.87	1.22	5.18	1.52	3.65	1.52	1.22	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	44.96	9.09	11.62	1.77	5.81	2.53	2.27	1.77	1.77	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	0.00	0.00	0.00	12.24	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	3.81	0.48	1.43	1.43	0.95	0.00	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	34.66	10.03	7.67	1.62	3.54	1.77	3.10	1.18	0.59	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	34.44	4.09	4.30	1.51	1.72	0.65	3.44	0.00	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	25.82	5.14	5.14	1.99	1.89	1.05	2.41	1.15	0.31	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	12.06	2.78	1.08	0.77	1.24	0.46	0.31	0.00	0.31	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	7.55	3.23	4.31	1.08	2.16	1.08	0.00	0.00	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	8.37	0.60	1.79	1.49	1.20	0.00	0.30	0.90	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	13.66	2.05	1.02	1.02	0.34	0.34	0.68	0.34	0.68	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	33.30	5.97	4.16	3.14	0.94	0.39	5.03	1.96	0.16	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	75.88	16.61	9.46	1.71	5.84	2.82	1.41	1.71	2.01	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	17.07	6.37	5.23	1.59	3.19	0.91	1.37	0.46	1.14	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	6.04	1.21	1.21	0.60	0.60	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	19.07	5.56	4.50	1.85	1.59	1.06	1.59	0.00	0.53	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	24.10	5.06	3.46	1.86	3.46	0.80	1.07	0.80	0.27	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	30.05	4.01	4.26	0.88	1.38	1.13	2.00	0.75	0.63	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	43.12	12.43	6.34	2.03	5.33	1.52	1.52	0.51	1.52	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	53.83	16.28	11.16	1.66	9.20	4.37	0.75	1.36	1.51	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	33.01	12.00	18.00	0.75	2.25	2.25	1.50	1.50	3.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	3.88	12.92	47.81	0.00	5.17	1.29	1.29	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	26.04	1.40	1.86	2.79	0.47	0.00	0.00	0.00	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	26.25	5.05	1.01	0.00	2.52	0.50	0.50	0.00	2.02	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	20.68	5.33	3.76	1.25	5.64	1.88	0.31	1.25	1.57	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	15.93	2.95	0.59	0.59	1.47	0.59	0.88	0.00	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	35.74	10.50	9.16	2.17	4.00	1.33	2.08	0.67	0.67	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	63.53	15.42	14.01	2.80	4.20	3.74	3.27	1.87	0.47	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	4.75	1.58	1.01	0.72	1.15	0.58	0.14	0.14	0.29	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	11.22	3.31	1.78	1.02	1.27	0.25	0.51	0.51	0.25	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	8.84	0.56	1.32	0.56	0.94	0.00	0.38	0.19	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	21.10	3.07	3.07	1.96	1.40	0.70	1.12	0.84	0.14	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	16.93	2.85	2.60	1.09	1.09	0.59	1.76	0.25	0.34	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	12.86	0.48	0.48	2.38	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	2.45	0.98	0.24	0.24	1.71	0.73	0.00	0.49	0.24	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	26.96	2.87	5.52	1.55	3.09	0.44	1.99	0.44	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	21.94	6.73	3.80	1.76	3.22	0.88	1.17	0.00	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	41.40	2.33	4.28	1.17	0.97	0.58	2.53	0.78	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	55.54	15.60	15.07	1.32	7.93	3.97	0.26	0.26	1.59	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	32.73	11.53	9.67	0.74	4.09	1.12	1.12	1.12	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	76.18	10.42	14.01	1.44	5.75	2.52	1.80	1.80	0.36	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	44.86	12.49	17.89	1.14	8.52	5.68	0.28	0.57	0.28	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	42.54	5.51	6.70	0.79	2.76	1.18	1.18	0.39	0.39	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	55.62	10.16	8.38	1.27	4.83	1.78	2.29	1.02	0.76	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	76.27	6.79	7.59	2.80	2.00	1.60	3.19	2.40	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	73.99	12.54	11.29	0.42	4.18	2.93	1.67	0.84	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	49.50	5.96	8.71	0.92	4.13	1.83	2.29	1.83	0.00	0.00
Synoviocyte, donor1	11291-117A4	32.32	8.42	5.89	0.50	5.89	2.69	2.19	0.67	0.17	0.00
Synoviocyte, donor2	11368-117I9	45.26	14.25	12.74	3.02	5.03	3.02	2.68	1.51	0.50	0.17
Synoviocyte, donor3	11440-118H9	25.25	7.60	9.16	2.90	2.68	2.23	0.89	0.45	1.56	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	23.58	0.71	0.71	0.71	0.36	1.07	0.36	0.36	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	15.86	0.00	3.96	0.00	0.00	1.98	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	18.06	2.55	1.62	1.39	0.23	0.23	0.00	0.23	0.69	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	5.95	0.50	0.29	1.08	0.36	0.07	0.29	0.00	0.00	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	7.34	0.39	0.00	0.77	0.39	0.39	0.77	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	5.15	0.00	0.00	0.00	0.00	0.57	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	38.01	6.40	3.94	6.15	2.95	1.60	3.69	0.98	0.49	0.12
Urethra, donor2	10319-105A4	97.12	3.60	1.80	7.19	1.80	1.80	3.60	1.80	0.00	1.80
Urothelial Cells, donor1	11520-119H8	2.66	0.00	0.00	0.00	0.00	0.00	0.27	0.27	0.00	0.27
Urothelial Cells, donor2	11600-120H7	6.01	0.40	0.00	0.80	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	3.44	0.00	0.00	0.46	0.00	0.00	0.23	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	8.69	1.11	1.34	1.11	0.22	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	16.91	3.56	1.78	2.67	1.78	0.00	1.78	0.89	0.00	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	21.44	7.15	0.00	1.43	1.43	0.00	2.86	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	14.37	6.85	2.05	3.42	0.00	0.00	0.68	0.68	0.68	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	28.92	4.48	1.72	3.10	1.72	0.00	0.34	0.69	0.00	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	38.93	12.20	2.91	4.07	0.58	1.16	1.74	1.74	0.00	2.32
Whole blood (ribopure), donor090612, donation1	12182-129A4	21.87	2.08	3.12	4.16	1.04	1.04	0.00	4.16	0.00	4.16
Whole blood (ribopure), donor090612, donation2	12183-129A5	14.68	2.75	5.51	1.84	1.84	0.00	1.84	0.92	0.92	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	20.08	3.65	3.65	4.56	0.91	0.91	0.00	2.74	0.00	2.74
Wilms' tumor cell line:G-401	10809-111A8	47.37	2.10	2.10	2.34	0.49	0.37	0.25	0.25	0.49	0.25
Wilms' tumor cell line:HFWT	10597-108E3	29.04	0.88	0.88	0.00	0.88	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	18.99	1.68	0.00	0.84	1.40	0.56	0.28	0.00	0.00	0.00
achilles tendon, donor2	10292-104G4	24.80	2.07	6.20	2.07	4.13	2.07	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	47.42	8.67	4.08	3.31	3.82	2.04	0.00	0.00	0.76	1.02
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	22.91	0.83	0.71	2.73	0.00	0.12	0.36	0.12	0.00	1.31
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	7.89	0.00	0.00	1.09	0.00	0.00	0.00	0.00	0.00	1.90
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	4.22	1.41	0.56	1.41	0.84	0.28	0.00	0.00	0.28	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	2.33	0.00	0.21	0.63	0.00	0.21	0.00	0.21	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	3.81	0.00	0.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	7.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	48.54	5.05	2.33	5.82	0.78	0.39	1.16	1.16	0.00	2.33
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	0.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	2.07	0.00	0.00	0.78	0.00	0.00	0.00	0.26	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	0.00	0.00	0.00	0.29	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	34.39	6.51	3.72	1.86	0.46	0.00	3.25	0.46	0.93	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	31.31	3.68	7.06	3.99	0.61	0.92	2.15	0.92	0.31	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	32.00	17.07	17.50	3.41	7.68	2.99	5.12	1.28	1.71	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	19.71	20.32	9.40	4.25	7.58	4.85	4.85	1.21	1.52	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	32.98	16.13	10.59	2.89	7.46	3.13	4.09	2.17	1.68	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	5.12	0.22	0.45	0.00	0.22	0.00	0.22	0.00	0.45	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	6.03	0.00	0.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	1.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	28.02	4.00	0.71	7.54	0.94	0.71	0.24	0.71	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	67.94	16.13	10.39	7.91	3.88	2.64	6.83	2.95	1.09	0.47
adipose, donor1	10184-103D4	35.18	0.00	1.17	7.62	0.00	0.00	0.59	0.00	0.59	0.59
adipose, donor2	10185-103D5	68.53	1.62	0.81	15.00	0.00	0.00	0.00	0.00	0.41	0.41
adipose, donor3	10186-103D6	74.33	1.09	2.72	12.25	1.63	0.27	0.27	0.00	0.27	0.27
adipose, donor4	10187-103D7	22.54	0.87	4.33	6.07	0.00	0.87	0.00	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	7.42	0.00	0.32	0.32	0.00	0.00	0.00	0.00	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	40.01	0.00	0.00	0.00	7.28	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	47.16	1.79	3.57	1.43	0.00	0.36	1.07	0.00	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	74.19	6.72	6.26	6.72	2.55	1.62	0.46	1.85	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	76.07	7.44	7.10	3.04	5.07	2.03	2.37	0.68	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	100.16	2.95	7.66	4.71	1.47	0.00	0.88	1.47	0.29	0.29
amygdala - adult, donor10196	10167-103B5	252.57	7.11	15.42	8.30	3.56	1.19	4.74	7.11	0.00	0.00
amygdala, adult, donor10252	10151-102I7	302.53	10.54	7.91	20.89	3.65	1.62	3.45	3.04	0.81	0.20
amygdala, newborn, donor10223	10360-105E9	276.61	11.30	8.39	7.75	4.52	0.97	2.26	0.97	0.32	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	35.53	4.07	1.53	4.97	0.64	0.13	0.76	0.00	0.00	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	12.35	7.06	3.97	0.88	5.74	2.43	1.32	0.88	0.44	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	3.34	0.00	0.00	0.67	0.00	0.00	0.00	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	58.25	5.88	4.90	8.04	2.75	0.98	1.57	0.98	0.00	0.00
appendix, adult	10189-103D9	96.25	11.26	6.99	8.93	5.05	3.49	2.33	0.39	0.00	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	37.49	4.47	3.10	5.50	2.06	0.34	0.00	0.69	0.00	0.69
artery, adult	10190-103E1	76.09	8.15	4.08	12.23	4.08	1.36	2.72	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	63.02	21.44	11.30	11.30	10.43	2.32	1.74	2.61	0.87	0.43
b cell line:RPMI1788	10427-106D4	38.81	6.10	1.93	4.61	6.25	1.04	0.15	0.45	0.15	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	48.28	15.81	11.65	1.94	10.82	5.83	0.55	0.00	1.39	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	3.97	0.60	0.00	0.10	0.30	0.10	0.00	0.10	0.00	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	27.28	2.68	1.51	3.01	0.67	0.33	0.84	0.84	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	20.69	3.36	2.24	1.68	2.24	0.56	1.12	0.00	1.12	0.00
bladder, adult, pool1	10011-101C2	85.94	6.74	5.43	8.91	1.96	1.63	2.93	1.63	0.54	0.22
blood, adult, pool1	10053-101G8	19.93	8.86	2.21	0.00	0.00	2.21	2.21	4.43	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	168.70	17.98	12.85	3.43	3.43	5.14	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	82.33	12.15	11.47	3.37	6.07	1.35	2.70	2.02	1.35	0.67
brain, adult, donor1	10084-102B3	59.45	4.10	0.00	3.08	0.00	0.00	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	63.47	7.57	4.45	6.57	2.67	0.56	0.78	2.12	0.33	0.33
brain, fetal, pool1	10085-102B4	98.84	2.67	2.67	5.34	2.67	0.00	0.00	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	13.54	1.32	0.66	0.99	0.00	0.33	0.33	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	51.18	1.87	1.12	4.74	0.75	0.12	0.00	0.25	0.00	0.00
breast, adult, donor1	10080-102A8	73.24	9.47	5.05	8.21	1.26	1.89	2.53	1.89	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	19.18	1.91	1.02	1.78	0.51	0.25	0.64	0.89	0.25	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	26.59	3.40	4.33	4.64	3.09	0.00	0.00	1.24	0.00	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	44.20	0.92	2.30	2.76	0.69	0.23	0.23	0.23	0.69	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	34.62	0.97	0.97	2.42	0.48	0.00	0.24	0.24	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	7.52	0.00	0.00	1.88	0.00	0.00	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	48.56	1.86	0.98	4.05	0.66	0.44	0.66	0.44	0.11	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	38.03	0.32	0.00	4.12	0.00	0.00	0.00	0.32	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	51.11	3.73	6.92	2.93	2.40	0.80	0.80	0.80	0.80	0.00
caudate nucleus - adult, donor10196	10177-103C6	46.05	4.61	4.61	2.30	1.15	0.00	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	38.82	3.51	1.84	5.52	1.34	0.84	0.67	0.67	0.50	0.17
caudate nucleus, adult, donor10258	10379-105H1	17.58	1.53	0.76	0.76	1.53	0.76	0.00	1.53	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	145.03	8.79	9.16	4.39	5.13	2.56	1.10	1.10	0.37	0.73
cerebellum - adult, donor10196	10173-103C2	233.06	5.83	29.13	8.74	17.48	5.83	2.91	14.57	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	148.60	23.49	10.25	28.18	27.76	5.12	5.34	5.98	1.07	0.43
cerebellum, adult, pool1	10083-102B2	98.31	8.62	7.93	16.21	9.66	2.76	4.83	5.17	0.69	1.03
cerebellum, newborn, donor10223	10357-105E6	386.08	17.44	22.42	18.27	9.96	0.00	5.81	5.81	0.83	0.00
cerebral meninges, adult	10188-103D8	92.79	5.29	5.04	9.08	2.27	0.50	1.01	2.52	0.25	0.25
cerebrospinal fluid, donor2	10294-104G6	26.31	1.46	0.73	1.46	1.46	0.00	0.73	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	19.70	1.87	1.15	3.31	1.73	0.43	0.58	0.14	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	22.54	2.15	0.99	3.15	1.82	0.66	0.83	0.83	0.33	0.17
cervix, adult, pool1	10013-101C4	53.65	5.46	5.14	10.39	0.94	0.00	3.04	1.47	0.63	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	7.66	0.56	0.56	1.11	0.28	0.14	1.25	0.28	0.00	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	35.27	2.61	0.00	3.92	2.61	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	23.36	1.37	0.87	3.48	1.37	0.12	0.87	0.50	0.00	0.00
choriocarcinoma cell line:SCH	10785-110H2	8.38	0.37	0.12	1.97	0.12	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	0.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	25.64	2.28	1.99	1.99	0.85	1.14	0.00	0.00	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	15.21	3.28	2.59	1.89	1.89	0.50	0.60	0.80	0.30	0.00
chorionic membrane cells, donor3	12240-129G8	6.04	0.00	1.10	0.00	0.00	0.00	0.55	1.10	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	22.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	5.57	0.96	0.96	1.73	0.19	0.00	0.38	0.19	0.00	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	0.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	0.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	5.49	0.23	0.91	1.60	0.00	0.00	0.00	0.00	0.46	0.46
clear cell carcinoma cell line:TEN	10636-108I6	17.87	1.91	1.21	0.87	1.39	0.17	0.17	0.69	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	41.55	7.87	3.29	3.48	2.56	1.28	0.92	0.92	0.73	0.18
colon carcinoma cell line:COLO-320	10420-106C6	75.64	8.36	4.18	6.08	1.52	1.14	0.00	2.28	0.00	0.00
colon, adult, donor1	10082-102B1	109.48	8.33	5.95	9.52	8.33	2.38	1.19	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	79.43	8.58	6.11	11.40	3.76	2.00	5.41	3.41	0.59	0.35
colon, fetal, donor1	10070-101I7	150.79	11.12	9.89	10.51	3.09	1.85	1.85	2.47	1.24	0.62
common myeloid progenitor CMP, donor1	12130-128D6	9.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	68.84	23.80	8.92	8.50	29.75	5.10	3.82	2.97	2.12	6.80
cord blood derived cell line:COBL-a 24h infection	10453-106G3	33.20	15.85	5.43	3.17	13.73	5.74	0.60	1.51	0.91	1.81
cord blood derived cell line:COBL-a untreated	10449-106F8	30.04	21.86	5.36	3.67	14.10	5.22	1.41	1.55	0.85	2.54
corpus callosum, adult, pool1	10042-101F6	44.67	4.86	3.98	6.19	1.77	0.77	0.44	0.88	0.11	0.11
cruciate ligament, donor2	10295-104G7	42.95	12.97	8.92	2.43	1.62	0.81	3.24	1.62	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	156.50	7.22	9.63	10.43	3.21	0.80	0.80	1.61	2.41	0.00
diencephalon, adult	10193-103E4	48.00	6.24	2.88	3.12	4.80	1.68	1.20	0.24	0.72	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	46.15	7.12	4.59	3.44	3.67	0.92	0.69	1.15	0.92	4.13
ductal cell carcinoma cell line:KLM-1	10438-106E6	16.93	1.54	0.00	1.28	1.03	0.26	0.00	0.26	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	20.46	1.93	0.48	1.44	0.48	0.00	0.00	0.00	0.24	0.00
ductus deferens, adult	10196-103E7	124.09	12.46	8.47	7.48	10.96	5.98	3.49	1.50	1.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	138.26	7.20	8.64	5.76	0.00	0.00	0.00	1.44	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	91.96	11.03	10.30	7.36	2.94	2.21	1.47	2.21	0.00	0.00
dura mater, adult, donor1	10041-101F5	37.58	14.70	13.79	5.37	3.88	2.31	4.05	1.24	1.24	0.50
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	33.53	0.89	0.67	2.66	3.55	0.22	0.22	0.67	0.44	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	28.52	1.29	0.57	2.87	0.57	0.00	0.57	0.72	0.43	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	27.13	3.70	2.47	3.70	0.62	0.62	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	43.29	2.42	3.03	5.15	1.21	0.91	0.61	0.61	0.91	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	31.18	2.78	1.85	4.01	0.62	1.23	0.31	0.62	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	22.33	1.31	2.63	2.63	0.00	0.00	0.00	0.00	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	40.89	4.36	4.02	4.69	1.68	0.00	0.34	0.34	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	27.73	4.35	3.99	3.26	0.91	0.18	0.36	0.36	0.72	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	3.22	4.18	3.38	0.32	1.93	0.64	0.48	1.13	0.32	0.16
epidermoid carcinoma cell line:A431	10426-106D3	19.45	1.33	0.89	1.89	0.78	0.22	0.11	0.00	0.00	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	9.35	1.32	1.10	0.77	1.10	0.11	0.33	0.11	0.11	0.00
epididymis, adult	10197-103E8	39.14	4.40	4.19	7.74	1.47	0.84	1.26	0.21	0.63	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	28.21	3.73	3.19	2.13	1.42	0.53	0.00	0.00	0.71	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	29.89	2.75	1.18	0.39	0.00	0.00	0.79	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	2.75	0.26	0.00	0.26	0.13	0.00	0.26	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	3.44	0.59	0.49	0.20	0.20	0.20	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	3.14	0.11	0.11	0.56	0.11	0.11	0.00	0.22	0.00	0.00
esophagus, adult, pool1	10015-101C6	53.73	4.35	2.76	5.63	1.70	0.53	2.02	1.38	0.11	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	82.66	4.51	6.14	8.77	0.88	0.50	0.13	0.50	0.75	1.13
eye - muscle inferior rectus, donor1	10272-104E2	103.83	4.83	4.83	12.07	4.83	0.00	4.83	2.41	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	42.08	0.00	0.00	6.31	0.00	2.10	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	61.02	2.98	7.44	7.44	1.49	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	35.54	1.15	0.00	5.73	3.44	0.00	2.29	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	64.13	2.91	8.74	10.20	1.46	0.00	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	78.05	4.07	4.32	12.71	2.80	1.02	1.02	1.78	0.51	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	5.77	0.51	0.38	0.77	0.13	0.13	0.00	0.13	0.00	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	13.06	1.90	1.42	0.95	0.71	0.24	0.95	0.00	0.00	0.24
frontal lobe, adult, pool1	10040-101F4	86.41	8.82	4.41	9.10	3.38	1.69	1.60	4.03	0.28	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	12.01	0.60	0.00	3.60	0.60	0.00	0.30	0.00	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	22.31	0.55	0.55	2.74	0.09	0.00	0.64	0.09	0.00	0.00
gall bladder, adult	10198-103E9	56.98	4.59	3.38	3.86	2.41	1.21	1.21	1.21	0.24	0.00
gamma delta positive T cells, donor1	11937-126A2	29.53	4.29	4.29	4.29	1.61	0.00	2.15	3.22	0.00	4.29
gamma delta positive T cells, donor2	11938-126A3	25.40	6.72	5.23	2.61	2.61	0.75	1.12	1.87	1.12	4.11
gastric adenocarcinoma cell line:MKN1	10614-108G2	4.65	0.21	0.42	0.00	0.42	0.00	0.00	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	90.13	5.80	3.67	8.12	3.67	1.35	0.97	0.97	0.00	0.19
gastric cancer cell line:AZ521	10549-107H9	0.66	0.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	26.54	0.00	0.92	4.58	0.92	0.00	0.00	0.92	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	120.17	18.05	12.34	9.37	10.51	5.48	2.06	2.28	0.69	0.46
giant cell carcinoma cell line:LU65	10487-107B1	3.56	0.80	0.23	0.80	0.46	0.00	0.00	0.11	0.00	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	18.05	2.66	2.24	2.52	0.28	0.28	0.42	0.28	0.14	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	5.49	0.00	0.00	0.25	0.00	0.00	0.00	0.00	0.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	10.34	3.06	2.32	0.63	0.42	0.42	0.42	0.00	0.32	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	14.32	2.53	2.81	1.40	0.84	0.14	0.00	0.00	0.14	0.14
glioblastoma cell line:T98G	10485-107A8	16.22	2.21	1.99	0.99	0.33	0.22	0.22	0.11	0.00	0.22
glioma cell line:GI-1	10413-106B8	10.25	0.00	0.59	0.88	0.29	0.29	0.88	0.00	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	75.08	4.37	5.83	4.37	1.46	0.73	0.73	0.73	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	52.24	4.64	2.93	7.81	2.69	0.73	0.24	0.24	0.49	0.24
globus pallidus, adult, donor10258	10367-105F7	31.49	1.37	2.74	9.58	1.37	1.37	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	128.97	9.06	5.33	3.20	3.73	1.07	2.13	1.07	0.00	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	41.60	0.00	0.00	0.00	2.45	0.00	2.45	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	39.36	4.48	3.20	3.20	1.28	0.00	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	17.91	0.46	0.92	0.00	0.46	0.00	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	15.55	0.00	1.37	0.91	0.00	0.46	0.46	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	14.81	0.64	1.29	1.29	0.64	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	17.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	10.29	0.00	0.69	0.69	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	57.38	1.10	0.00	2.21	1.10	2.21	1.10	2.21	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	17.82	6.32	4.02	2.01	4.02	1.15	0.29	0.00	0.00	2.01
heart - mitral valve, adult	10205-103F7	170.41	14.05	10.16	6.88	8.37	2.09	2.09	0.90	0.90	0.30
heart - pulmonic valve, adult	10206-103F8	138.06	12.81	8.37	10.46	8.37	2.88	1.31	3.66	0.26	0.00
heart - tricuspid valve, adult	10207-103F9	119.07	19.98	5.00	5.83	5.83	2.50	9.16	0.83	1.67	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	87.13	6.33	2.86	7.75	4.90	3.26	0.82	0.82	0.61	0.00
heart, adult, diseased, donor1	10051-101G6	153.30	11.92	2.55	14.48	4.68	2.55	1.70	0.85	0.85	0.00
heart, adult, pool1	10016-101C7	167.19	17.25	6.21	15.87	6.67	3.91	5.75	2.07	0.69	0.00
heart, fetal, pool1	10046-101G1	304.24	26.29	11.60	44.26	22.59	7.60	8.32	6.67	0.51	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	39.49	4.32	3.39	0.93	2.16	0.31	0.62	0.31	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	149.84	7.14	7.14	7.14	0.00	1.19	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	20.33	3.98	2.54	5.86	2.21	0.99	1.33	1.22	0.11	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	19.18	6.19	4.85	4.85	2.18	0.61	1.21	0.73	0.36	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	23.04	4.24	3.23	4.24	2.53	1.52	1.21	1.11	0.30	0.10
hepatoma cell line:Li-7	10484-107A7	61.28	5.00	3.45	4.89	3.67	1.33	1.00	0.67	0.78	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	17.89	2.71	1.71	2.01	3.82	0.80	0.00	0.10	0.20	0.40
hippocampus - adult, donor10196	10169-103B7	129.65	7.57	6.62	10.41	2.84	0.00	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	131.24	6.12	2.86	11.23	1.22	0.82	0.61	1.02	0.00	0.00
hippocampus, adult, donor10258	10374-105G5	84.65	6.47	3.98	1.49	2.49	1.49	2.49	1.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	109.97	2.82	2.82	9.52	2.11	2.47	1.06	0.70	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	17.09	0.00	0.00	1.83	0.00	0.61	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	16.89	0.20	0.00	1.96	0.00	0.00	0.00	0.20	0.20	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	15.49	0.00	0.25	1.02	0.25	0.00	0.25	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	39.47	1.13	0.00	3.95	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	42.86	0.26	0.00	6.46	0.26	0.00	0.26	0.26	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	31.13	0.38	0.00	4.93	0.00	0.00	0.38	0.00	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	75.03	0.88	0.58	6.42	1.17	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	89.40	1.29	2.37	10.13	0.00	0.43	0.86	0.43	0.65	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	87.17	0.00	1.25	7.09	1.67	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	50.67	3.55	2.84	2.13	0.95	0.47	0.95	0.47	0.00	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	77.14	4.66	3.54	6.75	1.13	0.80	0.48	0.48	0.48	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	96.96	3.37	2.69	12.79	0.00	0.00	0.67	0.67	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	9.55	0.00	0.00	0.63	0.31	0.00	0.00	0.00	0.00	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	11.79	0.00	0.00	1.97	0.49	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	4.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	83.24	0.76	0.38	10.50	0.38	0.19	0.38	0.76	0.57	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	90.70	0.44	1.74	12.21	0.00	0.44	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	83.46	1.00	0.00	5.00	1.00	0.50	0.00	0.50	0.50	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	59.53	0.94	1.88	11.30	0.19	0.19	0.57	0.57	0.94	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	56.84	0.91	1.82	9.55	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	54.82	0.63	0.94	6.58	0.63	0.31	0.63	0.31	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	68.59	1.80	2.45	7.02	1.47	0.33	0.00	0.16	0.49	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	67.35	3.19	4.06	5.81	1.16	0.29	0.58	0.58	0.58	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	72.94	2.99	2.09	6.28	0.30	0.60	0.90	0.00	0.60	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	17.00	0.18	0.55	0.74	0.37	0.00	0.00	0.00	0.18	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	14.83	0.00	0.00	1.14	0.57	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	14.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.41	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	60.56	1.76	1.06	8.10	0.70	0.00	0.00	0.35	0.35	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	58.91	1.90	0.95	10.14	0.32	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	60.22	0.61	0.30	4.84	0.30	0.30	0.00	0.61	0.91	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	56.37	0.52	0.52	7.24	0.52	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	69.74	0.66	1.33	5.98	0.66	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	38.74	1.54	1.80	3.85	0.00	0.51	0.00	0.26	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	64.93	4.60	4.60	4.35	2.81	0.26	0.77	0.26	0.77	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	77.24	3.03	3.79	6.06	0.00	0.00	0.00	0.00	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	87.71	3.02	5.71	4.03	2.35	1.01	0.34	1.01	1.01	2.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	12.08	0.00	0.00	1.69	0.00	0.00	0.00	0.24	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	11.14	0.00	1.34	0.00	0.45	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	18.54	0.00	0.00	0.98	0.00	0.00	0.49	0.00	0.00	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	53.79	0.31	0.31	9.17	0.31	0.00	0.31	0.00	0.00	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	22.77	3.25	0.00	0.00	0.00	0.00	0.00	0.00	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	41.70	0.66	0.66	4.30	0.00	0.00	0.00	0.00	0.99	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	49.26	1.64	2.19	6.02	0.00	0.00	0.55	0.00	0.55	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	50.30	0.72	1.09	4.70	0.00	0.00	0.00	0.00	0.72	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	45.91	2.14	0.00	7.47	0.36	0.00	0.36	0.36	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	83.54	1.19	7.16	5.97	2.39	0.00	0.00	1.19	1.19	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	84.23	6.91	3.93	7.04	1.08	0.68	0.27	1.08	0.68	0.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	81.36	2.69	3.50	4.04	1.35	0.54	0.54	0.27	0.54	0.54
immature langerhans cells, donor1	11904-125F5	2.66	0.24	0.48	0.24	0.48	0.00	0.00	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	16.63	0.79	0.79	2.38	0.00	0.00	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	125.96	8.80	6.53	12.30	3.88	1.32	2.74	2.93	0.66	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	38.37	0.33	1.95	4.55	0.65	0.00	0.33	0.98	0.00	0.33
kidney, adult, pool1	10017-101C8	20.33	4.21	3.30	2.60	1.20	1.00	1.00	0.50	0.10	0.10
kidney, fetal, pool1	10045-101F9	41.80	5.16	3.82	6.79	1.70	0.71	1.77	1.06	0.21	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	35.08	3.12	2.70	2.56	1.70	0.00	0.85	0.28	0.28	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	28.89	2.76	2.07	1.80	1.11	0.28	0.41	0.00	0.41	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	10.46	1.28	0.73	1.47	1.28	0.18	0.00	0.00	0.18	0.00
left atrium, adult, donor1	10079-102A7	99.16	9.81	5.99	6.54	5.99	1.63	0.54	0.54	0.54	0.00
left ventricle, adult, donor1	10078-102A6	175.97	14.16	8.60	13.15	3.03	2.02	0.51	0.00	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	4.10	0.27	0.00	0.27	0.00	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	46.34	12.57	11.86	0.72	5.03	2.51	0.36	0.36	2.16	0.00
leiomyoma cell line:15242A	10570-108B3	38.04	6.52	4.89	2.72	8.70	5.43	0.54	1.09	1.09	0.00
leiomyoma cell line:15425	10571-108B4	30.59	7.28	9.23	2.43	5.10	2.91	1.70	0.97	0.24	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	38.10	19.05	0.00	0.00	19.05	6.35	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	5.23	2.09	2.09	1.05	1.05	0.00	0.00	0.00	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	31.87	3.59	3.75	2.19	2.03	1.41	0.47	0.16	0.16	0.00
liposarcoma cell line:SW 872	10726-110A6	16.69	1.22	1.58	2.80	0.37	0.00	0.24	0.73	0.24	0.00
liver, adult, pool1	10018-101C9	12.64	2.27	2.92	3.89	2.11	0.97	0.32	0.81	0.16	0.00
liver, fetal, pool1	10086-102B5	39.51	1.88	5.64	2.82	2.82	1.88	2.82	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	76.41	5.25	3.65	5.10	2.62	1.02	0.58	1.02	0.44	0.15
locus coeruleus, adult, donor10252	10165-103B3	56.47	6.27	4.06	8.49	4.06	1.85	1.48	1.48	0.37	0.00
locus coeruleus, adult, donor10258	10375-105G6	79.85	5.64	4.80	7.34	1.69	0.56	0.85	0.85	0.56	0.56
locus coeruleus, newborn, donor10223	10362-105F2	106.00	11.36	5.05	2.94	5.89	0.84	0.84	4.21	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	27.96	4.43	1.94	1.94	1.52	0.97	0.55	0.55	0.14	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	22.06	0.69	0.00	2.07	0.00	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	52.99	5.54	3.56	5.67	0.53	0.79	0.66	0.66	0.00	0.26
lung, adult, pool1	10019-101D1	62.84	9.69	6.62	8.03	3.07	1.77	2.13	1.77	0.35	0.59
lung, fetal, donor1	10068-101I5	117.59	12.84	24.55	9.99	9.70	1.71	9.13	4.57	0.86	0.00
lung, right lower lobe, adult, donor1	10075-102A3	47.20	5.04	8.25	6.87	2.75	0.92	1.37	0.46	0.46	0.00
lymph node, adult, donor1	10077-102A5	51.60	5.21	9.94	5.68	3.31	0.47	0.47	0.47	0.95	1.42
lymphangiectasia cell line:DS-1	10727-110A7	8.99	0.66	0.00	0.66	0.22	0.00	0.22	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	40.15	15.09	6.49	4.08	26.71	4.23	0.60	1.51	0.15	4.83
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	28.03	6.80	3.40	2.55	1.70	1.70	0.00	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	65.71	8.44	4.00	10.66	1.78	0.44	1.33	1.78	0.00	0.44
mature adipocyte, donor2	12232-129F9	79.28	9.34	8.30	13.70	5.81	1.45	2.70	1.87	0.83	0.00
mature adipocyte, donor3	12233-129G1	54.05	12.33	9.72	8.53	4.50	2.13	1.66	1.90	0.71	0.24
mature adipocyte, donor4	12234-129G2	49.48	8.42	8.42	6.32	3.95	1.84	1.84	0.53	0.53	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	44.79	0.95	1.19	4.05	1.43	0.00	1.19	0.24	0.48	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	81.22	6.77	2.26	3.38	1.13	2.26	0.00	3.38	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	68.78	5.70	2.94	8.64	1.29	1.29	1.66	1.29	0.37	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	69.26	4.77	3.81	4.77	3.18	0.32	0.95	0.95	0.64	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	69.94	12.79	8.96	3.84	5.97	2.56	2.13	0.85	0.43	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	157.11	10.46	6.41	10.29	4.56	1.52	0.84	2.19	1.35	0.51
medial temporal gyrus, adult, donor10252	10156-103A3	86.80	5.94	4.24	8.70	2.33	1.06	1.27	1.06	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	92.46	5.78	1.93	1.93	5.78	0.00	3.85	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	143.54	28.71	28.71	14.35	0.00	0.00	0.00	28.71	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	179.11	8.61	7.54	5.03	5.38	2.51	1.08	0.36	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	55.16	3.89	3.89	2.60	1.95	0.00	0.00	1.30	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	41.80	6.66	3.25	8.82	3.72	1.08	0.31	1.08	0.15	0.00
medulla oblongata, adult, pool1	10038-101F2	37.30	5.55	5.31	5.47	4.57	0.90	1.22	0.82	0.16	0.08
medulla oblongata, newborn, donor10223	10361-105F1	86.45	7.99	5.21	2.43	2.43	0.69	1.39	1.39	0.69	0.00
medulloblastoma cell line:D283 Med	10838-111E1	20.37	1.33	0.44	1.11	0.66	0.22	0.00	0.00	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	21.52	1.35	0.61	0.86	0.24	0.24	0.37	0.00	0.12	0.00
melanoma cell line:COLO 679	10514-107E1	15.81	1.87	0.86	1.58	0.57	0.43	0.43	0.72	0.29	0.14
melanoma cell line:G-361	10465-106H6	10.59	1.36	1.09	1.36	0.27	0.27	0.00	0.00	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	6.33	0.36	0.54	1.63	0.72	0.18	0.54	0.18	0.00	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	7.93	0.00	0.00	0.88	0.88	0.00	0.88	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	17.89	0.52	1.04	2.33	0.52	0.00	0.26	0.52	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	27.31	6.29	6.44	1.23	2.61	1.23	0.31	0.61	0.46	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	23.81	3.64	3.82	0.55	1.45	1.09	0.18	0.36	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	40.17	10.77	11.18	1.66	4.97	3.31	1.24	1.24	2.90	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	38.49	18.96	13.91	1.97	10.11	5.48	2.67	1.26	2.25	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	41.98	17.91	19.06	2.31	8.86	5.78	2.70	1.35	2.31	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	70.80	29.85	29.15	2.08	12.49	3.47	2.08	3.47	2.78	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	21.80	11.16	8.92	0.69	7.21	2.92	1.03	0.86	0.86	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	58.66	25.42	28.64	3.11	13.23	9.32	3.57	2.76	3.22	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	23.48	5.44	5.04	2.92	2.25	1.33	1.33	0.27	0.27	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	21.34	7.97	6.08	1.08	4.05	2.03	1.49	0.68	0.81	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	7.97	3.13	1.28	0.85	1.85	0.57	0.85	0.57	0.28	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	8.89	1.65	0.99	0.33	0.99	0.33	0.66	0.33	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	9.27	2.08	3.18	0.97	1.11	0.28	0.14	0.14	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	28.28	7.68	8.38	2.44	1.75	2.44	1.05	0.70	1.05	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	12.05	1.84	2.04	1.63	1.22	0.82	0.20	0.61	0.20	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	14.02	2.88	2.16	1.44	0.72	0.36	0.36	0.36	0.00	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	8.90	1.03	2.07	0.72	0.62	0.10	0.52	0.41	0.21	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	10.72	3.88	4.56	1.14	2.28	0.68	0.23	0.23	0.46	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	14.26	5.03	4.62	0.84	0.84	0.84	0.84	0.42	0.00	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	10.31	3.59	3.59	0.75	1.64	0.75	0.30	0.15	0.15	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	7.70	1.84	1.58	1.14	0.88	0.18	0.18	0.00	0.18	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	50.81	7.00	6.63	5.15	2.21	2.58	1.10	0.37	0.37	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	13.74	4.01	3.43	0.29	1.72	0.57	0.29	0.00	0.00	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	69.89	11.79	4.63	3.37	5.05	1.26	0.84	2.95	1.26	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	54.80	6.85	9.13	1.83	2.28	0.91	0.46	0.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	45.02	10.23	6.39	1.53	3.07	1.28	1.28	0.26	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	54.18	7.33	6.54	2.09	2.09	0.79	1.05	1.05	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	60.08	8.32	7.70	1.54	2.77	1.54	1.85	1.23	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	45.42	6.35	8.94	0.94	1.88	1.18	2.12	0.47	0.71	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	59.91	7.45	6.09	1.69	2.37	0.68	1.02	0.00	1.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	51.87	6.29	4.32	2.36	2.75	1.18	1.57	1.18	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	48.66	6.49	5.56	2.32	2.32	1.85	4.17	1.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	62.87	6.92	8.65	2.31	3.46	1.44	0.58	1.44	1.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	48.41	7.36	6.92	2.01	1.78	2.23	2.01	0.89	0.67	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	54.56	9.61	7.93	1.92	1.92	1.44	1.20	0.24	0.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	83.60	6.60	11.00	3.67	2.93	2.20	1.47	0.00	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	53.71	6.04	8.06	1.34	2.35	0.67	1.68	1.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	53.22	6.55	7.78	1.64	2.05	0.00	3.68	0.41	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	61.00	10.31	9.02	1.29	0.86	0.43	0.86	0.86	0.86	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	71.09	5.47	0.00	0.00	2.73	0.00	0.00	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	56.81	15.49	5.16	0.00	10.33	0.00	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	50.67	9.09	4.87	2.27	3.57	1.62	1.95	0.65	0.00	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	66.93	10.18	4.36	1.45	5.82	2.91	0.00	1.45	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	67.70	10.66	6.40	1.60	3.20	1.60	1.60	0.53	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	59.70	12.27	4.09	3.27	2.45	0.82	0.00	3.27	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	56.75	6.61	7.00	2.72	3.11	1.17	0.00	0.39	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	79.75	4.20	2.10	2.10	4.20	4.20	0.00	4.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	59.61	2.98	9.93	0.00	2.98	0.99	1.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	38.14	4.77	4.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	56.92	8.89	4.15	1.19	1.78	1.19	2.37	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	51.18	1.22	6.09	2.44	2.44	1.22	1.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	50.04	5.70	4.43	2.53	0.63	0.63	0.63	0.00	0.63	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	34.49	3.79	3.10	0.69	0.69	0.34	2.07	1.03	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	53.73	0.00	2.15	2.15	0.00	0.00	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	47.90	3.99	0.00	0.00	0.00	0.00	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	6.89	6.89	0.00	0.00	6.89	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	22.00	2.85	2.04	1.22	0.00	0.00	2.04	0.81	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	27.01	2.38	1.59	3.18	0.79	0.00	1.59	1.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	24.17	4.72	4.13	0.59	1.77	0.00	1.77	1.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	30.86	2.49	2.18	1.25	1.87	0.00	2.49	0.94	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	37.43	2.67	5.35	1.34	1.34	0.00	0.00	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	57.95	8.28	9.46	1.18	1.18	0.00	8.28	1.18	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	53.93	15.41	7.70	0.00	5.14	0.00	2.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	50.94	11.70	8.26	0.69	0.69	1.38	4.13	1.38	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	34.64	7.92	3.96	0.99	2.47	0.99	0.99	1.48	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	48.22	3.36	2.24	3.36	3.36	0.00	3.36	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	22.90	4.45	8.27	3.18	0.64	0.64	3.82	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	21.76	4.43	1.21	1.61	1.21	0.81	2.42	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	23.99	4.36	2.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	15.20	1.27	0.00	1.27	1.27	0.00	2.53	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	23.06	2.43	4.25	2.43	1.82	1.21	3.03	0.00	0.61	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	67.78	9.04	0.00	0.00	9.04	0.00	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	41.18	3.29	4.12	4.94	0.00	0.82	4.12	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	77.98	8.93	7.54	2.38	2.18	1.39	1.79	0.79	0.40	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	49.00	6.17	5.52	3.24	1.95	2.27	2.60	1.30	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	65.19	8.15	7.13	2.04	2.04	1.02	3.06	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	47.97	9.28	8.51	4.64	3.09	0.77	1.55	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	47.48	1.89	3.54	5.67	1.65	0.24	0.71	0.47	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	15.29	0.23	1.62	1.62	0.23	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	21.37	8.55	4.27	0.00	0.00	0.00	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	33.39	3.19	2.06	1.54	1.03	0.41	0.21	0.21	0.51	0.00
mesothelioma cell line:Mero-25	10850-111F4	6.81	0.91	0.68	0.68	0.23	0.23	0.00	0.45	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	1.47	0.00	0.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	5.31	0.89	0.66	0.22	0.44	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	19.18	1.05	1.31	0.79	0.53	0.26	0.00	0.00	0.26	0.00
mesothelioma cell line:Mero-83	10854-111F8	3.57	0.17	0.34	0.17	0.00	0.17	0.00	0.17	0.00	0.00
mesothelioma cell line:Mero-84	10855-111F9	6.07	1.26	2.27	0.25	0.51	0.51	0.51	0.00	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	20.29	1.04	1.24	0.83	0.00	0.00	0.62	0.41	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	19.05	4.47	5.63	1.49	1.82	0.50	0.83	0.50	0.17	0.00
mesothelioma cell line:NCI-H226	10846-111E9	24.61	1.27	1.81	0.90	0.36	0.54	0.72	0.36	0.36	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	23.23	4.10	2.90	1.20	2.90	1.02	0.17	0.51	0.34	0.34
mesothelioma cell line:NCI-H28	10845-111E8	2.80	0.00	1.02	0.25	0.00	0.00	0.00	0.25	0.00	0.00
mesothelioma cell line:No36	10857-111G2	39.47	3.91	3.91	0.98	1.30	0.65	0.65	0.33	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	9.21	3.25	0.81	0.81	0.54	0.00	1.35	0.54	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	0.58	0.58	0.38	0.58	0.38	0.19	0.00	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	0.61	0.37	0.24	0.37	0.12	0.00	0.00	0.00	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	0.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	17.96	0.65	0.00	1.96	0.65	0.33	0.65	0.33	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	8.69	1.27	1.91	1.91	1.06	1.06	0.21	0.00	0.21	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	36.17	1.38	1.15	1.15	0.92	0.00	0.00	0.00	0.23	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	40.34	5.90	3.04	3.81	2.47	1.33	0.38	0.76	0.95	0.95
myelodysplastic syndrome cell line:SKM-1	10772-110F7	7.21	1.66	1.48	1.29	0.74	0.92	0.74	0.55	0.37	0.00
myeloma cell line:PCM6	10474-106I6	12.65	3.95	1.58	1.38	1.19	0.59	0.00	0.20	0.20	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	28.41	3.55	1.52	1.01	2.03	0.00	0.00	0.00	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	8.83	2.55	2.94	0.98	0.78	0.78	0.00	0.20	0.20	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	21.28	1.23	0.45	1.45	0.22	0.11	0.67	0.45	0.11	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	24.64	0.51	0.37	2.57	0.29	0.15	0.37	0.29	0.00	0.07
nasal epithelial cells, donor2	12227-129F4	23.18	0.00	1.66	2.21	0.00	0.55	0.55	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	41.41	1.61	1.15	6.67	0.46	0.23	0.00	0.46	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	47.15	5.61	4.86	5.99	1.50	0.75	0.94	0.75	0.00	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	16.66	0.21	0.42	2.32	0.00	0.00	0.00	0.42	0.00	0.21
neuroblastoma cell line:NH-12	10555-107I6	38.20	1.30	2.05	4.47	0.56	0.00	0.19	0.19	0.19	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	7.83	0.00	0.00	0.71	0.00	0.00	0.24	0.00	0.00	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	9.82	0.00	0.32	0.79	0.00	0.00	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	2.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	7.63	0.00	0.00	0.00	0.64	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	103.54	11.18	6.92	2.93	3.99	4.79	1.06	0.27	0.53	0.27
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	14.71	2.37	1.35	4.90	0.34	0.34	0.00	0.00	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	48.83	3.20	0.80	2.40	3.20	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	47.45	14.11	10.26	2.56	1.28	1.92	0.64	1.28	1.28	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	13.66	3.15	2.36	1.31	2.10	0.26	1.58	0.00	1.05	0.00
nucleus accumbens, adult, pool1	10037-101F1	68.52	5.16	3.84	8.06	2.53	0.94	1.12	2.81	0.47	0.00
occipital cortex - adult, donor10196	10172-103C1	59.75	4.12	6.18	2.06	4.12	0.00	4.12	4.12	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	54.48	5.64	2.15	8.86	1.07	0.54	1.07	0.54	0.27	0.27
occipital cortex, newborn, donor10223	10355-105E4	104.45	3.64	2.55	3.64	1.82	1.82	0.73	2.91	0.36	0.00
occipital lobe, adult, donor1	10076-102A4	87.90	5.25	4.72	9.45	1.57	1.31	2.10	2.89	0.26	0.00
occipital lobe, fetal, donor1	10073-102A1	105.99	1.72	1.72	9.87	0.43	0.00	0.43	0.43	0.00	0.43
occipital pole, adult, pool1	10036-101E9	37.61	1.97	2.29	5.68	1.58	0.55	0.95	1.50	0.08	0.00
olfactory region, adult	10195-103E6	116.54	5.16	4.39	8.02	3.44	0.38	0.57	1.15	0.00	0.19
optic nerve, donor1	10277-104E7	68.04	2.00	6.00	18.01	2.00	0.00	2.00	0.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	13.67	1.94	0.57	2.16	1.37	0.46	0.00	0.11	0.00	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	14.98	2.75	1.24	3.43	1.37	0.27	0.27	0.27	0.14	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	13.88	0.85	1.19	0.68	0.68	0.00	0.51	0.17	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	6.47	0.46	0.58	0.58	0.35	0.23	0.00	0.00	0.00	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	46.74	6.76	7.64	2.94	3.53	1.47	1.76	0.29	0.00	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	36.44	0.93	0.93	1.87	1.87	0.00	0.00	0.00	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	83.76	14.42	8.48	4.45	5.51	3.82	0.00	1.27	0.64	0.64
ovary, adult, pool1	10020-101D2	41.84	5.07	3.58	6.73	1.92	0.44	2.62	1.48	0.00	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	15.95	0.37	0.55	2.02	0.37	0.00	0.00	0.00	0.00	0.18
pancreas, adult, donor1	10049-101G4	12.23	1.88	0.94	7.53	0.94	0.00	1.88	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	19.85	0.00	0.00	1.40	0.00	0.28	0.28	0.28	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	26.23	7.33	3.92	3.07	6.13	0.85	1.36	0.68	0.85	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	14.57	2.48	0.17	1.32	1.16	0.66	0.17	0.17	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	56.56	5.40	3.84	5.49	2.38	1.10	1.10	2.65	0.46	0.27
parietal cortex, adult, donor10258	10373-105G4	27.89	2.20	4.40	2.20	0.73	0.00	0.73	0.73	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	97.81	4.70	5.64	0.94	0.94	0.00	1.88	2.82	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	63.85	6.27	2.57	8.27	2.00	1.14	0.57	0.57	0.57	0.00
parietal lobe, adult, pool1	10034-101E7	54.81	4.23	2.11	7.58	2.82	0.97	1.06	2.03	0.53	0.09
parietal lobe, fetal, donor1	10072-101I9	101.83	1.94	3.88	13.58	0.97	0.00	0.97	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	161.88	7.85	10.84	6.73	5.23	0.75	0.75	0.75	0.00	0.37
parotid gland, adult	10199-103F1	16.65	1.23	0.00	2.47	0.62	0.62	0.62	0.00	0.00	0.00
penis, adult	10200-103F2	46.73	8.06	6.98	2.69	1.61	2.15	0.54	0.00	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	19.71	0.19	1.30	2.79	0.00	0.00	0.19	0.74	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	9.91	1.60	1.46	1.17	1.17	0.58	0.29	0.15	0.00	0.00
pineal gland - adult, donor10196	10179-103C8	44.51	5.16	4.52	1.94	0.65	0.65	0.65	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	17.77	3.55	1.78	3.55	0.59	0.00	1.78	0.59	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	26.34	0.63	2.51	2.51	0.63	0.00	0.00	0.63	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	33.39	4.05	4.05	4.05	5.06	1.01	1.01	1.01	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	38.57	9.90	7.30	8.34	6.78	1.56	4.17	2.61	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	22.13	1.70	2.55	0.85	1.70	0.00	4.26	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	10.11	1.72	1.83	1.40	0.54	0.00	0.54	0.43	0.11	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	33.90	3.97	0.93	2.25	3.05	0.79	0.13	0.26	0.13	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	39.84	4.05	3.11	2.80	2.49	1.40	1.09	0.31	0.16	0.00
pons, adult, pool1	10033-101E6	34.08	5.51	5.16	4.22	4.82	1.12	1.03	2.24	0.95	0.09
postcentral gyrus, adult, pool1	10032-101E5	46.64	3.40	2.96	5.58	2.35	1.05	1.66	1.66	0.17	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	4.18	0.00	0.00	0.00	2.09	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	12.96	1.46	1.60	1.17	1.17	0.58	0.15	0.87	0.00	0.00
prostate cancer cell line:PC-3	10439-106E7	22.51	5.08	5.26	3.09	1.82	0.54	0.18	0.54	0.36	0.18
prostate, adult, pool1	10022-101D4	59.68	6.08	3.08	7.44	1.45	0.73	4.35	1.81	0.45	0.18
putamen, adult, donor10196	10176-103C5	58.78	2.12	1.89	7.55	0.47	0.24	1.65	1.42	0.24	0.00
putamen, adult, donor10252	10152-102I8	50.98	1.96	3.92	5.88	1.96	1.96	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	20.76	1.09	1.09	1.09	0.00	0.00	2.19	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	18.12	0.72	1.93	1.93	1.69	0.48	0.97	0.24	0.00	0.24
putamen, newborn, donor10223	10365-105F5	107.95	14.99	12.74	4.50	5.25	1.50	6.00	3.75	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	22.40	0.29	0.29	3.78	0.58	0.29	0.29	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	203.08	19.47	12.52	8.35	5.56	1.39	1.39	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	19.08	1.06	0.64	2.33	0.21	0.00	0.21	0.21	0.42	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	27.75	4.14	0.83	7.87	0.00	0.41	0.00	0.41	0.00	0.83
retina, adult, pool1	10030-101E3	49.20	6.36	4.97	8.05	2.88	0.70	1.79	1.89	0.40	0.20
retinoblastoma cell line:Y79	10475-106I7	35.59	1.04	1.04	5.46	0.00	0.00	0.26	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	0.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	56.52	2.53	3.37	5.06	1.12	0.84	0.56	0.56	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	87.15	6.06	4.55	3.79	3.03	2.27	0.76	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	48.07	9.06	5.18	2.10	4.69	1.62	2.43	1.78	1.13	0.16
salivary acinar cells, donor2	11772-123I8	48.74	5.78	5.65	2.48	2.89	0.83	4.27	1.38	0.28	0.00
salivary acinar cells, donor3	11773-123I9	116.52	9.93	5.96	6.62	7.28	1.32	7.28	1.99	0.66	0.00
salivary gland, adult, pool1	10093-102C3	14.30	1.14	1.14	3.43	1.72	0.57	0.57	0.57	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	5.40	2.87	2.28	0.76	1.43	0.17	0.25	0.42	0.00	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	3.64	2.35	1.76	0.35	1.18	0.24	0.47	0.12	0.00	0.47
seminal vesicle, adult	10201-103F3	217.98	20.63	13.23	13.23	14.28	4.76	4.76	2.65	1.59	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	11.90	0.49	0.73	0.24	0.49	0.00	0.00	0.24	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	11.32	2.26	2.77	1.01	1.01	0.50	0.00	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	5.02	3.01	0.00	1.00	1.00	0.00	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	5.51	0.27	0.00	0.94	0.00	0.00	0.27	0.00	0.00	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	19.34	4.31	1.88	2.43	3.21	0.77	0.44	0.88	0.22	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	12.77	3.61	3.23	1.29	1.81	1.42	0.26	0.13	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	215.64	10.64	6.38	16.31	12.06	4.26	3.55	0.71	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	153.64	12.35	6.00	16.55	8.28	3.36	3.36	1.20	0.72	0.00
skeletal muscle, fetal, donor1	10066-101I3	148.74	6.03	6.03	6.03	3.02	1.01	1.01	0.00	1.01	0.00
skin, adult, donor1	10074-102A2	74.64	0.00	0.00	13.57	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	114.25	7.57	5.68	10.10	0.63	1.89	3.79	1.89	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	27.35	4.34	2.00	4.00	1.33	0.33	0.33	0.67	0.00	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	23.64	1.26	2.21	1.89	1.89	0.00	0.00	0.32	0.32	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	4.24	0.00	0.19	0.39	0.00	0.00	0.00	0.00	0.19	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	10.55	2.14	0.66	0.82	1.81	0.49	0.00	0.33	0.33	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	23.16	0.32	0.16	2.09	0.64	0.00	0.00	0.16	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	41.40	4.14	3.27	5.67	4.36	1.31	0.87	1.09	0.00	0.87
small intestine, adult, pool1	10024-101D6	86.95	15.65	6.57	10.99	9.56	3.22	3.70	3.22	0.24	0.24
small intestine, fetal, donor1	10064-101I1	62.65	9.34	6.14	7.13	3.93	0.49	3.93	0.98	0.25	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	26.67	5.13	0.51	4.10	1.03	0.51	0.51	0.00	0.51	0.51
smooth muscle, adult, pool1	10048-101G3	86.84	9.30	9.05	13.96	2.07	1.81	4.65	2.33	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	72.90	2.14	2.41	5.63	1.61	0.54	0.27	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	111.03	4.82	4.36	8.49	3.21	0.92	0.69	0.46	0.00	0.00
spinal cord, adult, donor10252	10159-103A6	56.38	7.49	3.94	6.70	0.79	0.00	0.79	0.79	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	33.21	2.08	2.08	1.38	2.08	0.00	0.00	1.38	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	99.40	7.32	2.44	15.25	4.88	0.61	1.22	1.83	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	70.72	9.18	5.97	4.59	2.30	0.46	0.00	0.46	1.38	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	51.38	7.62	3.29	2.69	2.24	1.05	0.90	0.30	0.60	0.00
spleen, adult, pool1	10025-101D7	18.50	7.82	3.96	3.52	2.53	1.43	0.88	0.44	0.22	0.88
spleen, fetal, pool1	10044-101F8	51.33	7.23	5.72	6.36	3.58	1.59	2.70	0.72	0.79	0.95
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	15.22	4.66	1.97	1.55	3.21	0.62	0.10	0.52	0.52	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	22.79	1.33	0.00	1.14	0.38	0.19	0.00	0.19	0.38	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	62.90	3.84	1.40	6.29	1.40	0.35	2.10	2.10	0.70	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	65.29	1.95	3.13	3.52	1.95	0.39	1.95	1.17	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	28.70	4.95	1.35	4.95	1.58	0.34	1.46	0.45	0.00	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	51.68	1.69	0.42	2.54	0.42	0.00	0.85	0.42	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	33.85	2.12	1.27	2.12	0.85	0.00	0.00	0.42	0.85	0.42
stomach, fetal, donor1	10062-101H8	242.43	17.09	13.88	35.24	6.41	2.14	4.27	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	18.80	3.42	2.28	6.84	1.14	0.00	1.14	1.71	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	162.82	54.27	0.00	0.00	54.27	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	41.54	4.36	3.95	6.65	1.25	0.00	0.62	0.42	0.21	0.00
substantia nigra, adult, donor10258	10371-105G2	62.59	4.14	3.10	3.62	4.14	1.03	1.55	1.55	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	142.73	5.65	4.95	8.48	3.53	2.12	1.41	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	16.28	0.00	0.23	1.38	0.69	0.00	0.00	0.00	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	88.50	3.65	2.80	8.65	1.70	1.10	1.44	1.95	0.85	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	92.59	1.42	0.71	11.40	0.00	0.00	0.71	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	75.16	0.00	1.76	6.59	1.32	0.00	0.44	0.44	0.44	0.00
tenocyte, donor1	11763-123H8	40.50	15.01	12.57	2.44	5.93	3.14	1.05	0.35	0.35	0.00
tenocyte, donor2	11765-123I1	33.57	18.31	16.40	1.91	7.63	2.29	2.29	1.14	1.91	0.00
tenocyte, donor3	11768-123I4	44.11	15.20	12.60	1.48	6.30	2.97	2.22	0.74	0.74	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	27.19	1.53	1.70	3.91	1.19	0.68	0.34	0.00	0.34	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	35.61	1.08	1.54	3.08	0.92	0.46	0.15	0.46	0.00	0.00
teratocarcinoma cell line:PA-1	10807-111A6	56.10	1.39	1.24	3.10	0.46	0.31	0.00	0.15	0.00	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	13.71	0.63	0.51	0.76	0.38	0.13	0.00	0.25	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	23.82	0.76	0.38	1.51	0.00	0.00	0.38	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	51.04	4.69	3.93	4.04	3.93	1.85	0.33	0.87	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	4.56	0.00	0.00	0.33	0.00	0.00	0.00	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	56.05	10.52	5.69	7.41	2.79	1.40	1.72	0.97	0.21	0.00
testis, adult, pool2	10096-102C6	47.82	8.12	5.86	1.80	1.35	0.45	0.90	0.45	0.00	0.45
thalamus - adult, donor10196	10168-103B6	213.07	11.04	8.83	11.04	6.62	0.00	4.42	1.10	0.00	1.10
thalamus, adult, donor10252	10154-103A1	48.14	5.31	3.28	9.22	1.56	0.78	0.31	0.47	0.31	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	130.87	9.24	9.24	1.54	7.70	0.00	1.54	1.54	0.00	4.62
thalamus, adult, donor10258, tech_rep2	10370-105G1	168.64	7.25	6.75	8.56	7.58	2.14	0.99	0.49	0.33	0.82
thalamus, newborn, donor10223	10366-105F6	251.99	17.83	12.08	6.33	12.08	2.30	4.03	3.45	2.88	0.58
throat, adult	10209-103G2	42.44	5.24	4.24	5.74	3.50	0.50	0.75	0.75	0.50	0.00
throat, fetal, donor1	10061-101H7	122.19	7.62	5.79	13.71	3.96	2.13	0.61	1.22	0.61	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
thymus, adult, pool1	10027-101D9	54.38	2.39	1.59	8.95	0.70	0.60	0.20	0.40	0.60	0.80
thymus, fetal, pool1	10043-101F7	67.12	8.21	2.81	12.36	2.39	1.04	1.14	1.04	0.21	0.94
thyroid carcinoma cell line:KHM-5M	10776-110G2	13.16	0.93	0.80	0.93	0.66	0.00	0.27	0.27	0.13	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	38.83	4.61	3.35	2.10	2.10	0.84	0.28	0.42	0.00	0.28
thyroid, adult, pool1	10028-101E1	44.98	5.23	3.08	7.56	1.96	1.40	2.24	1.03	0.09	0.00
thyroid, fetal, donor1	10060-101H6	89.38	5.80	5.27	10.28	1.58	0.53	1.05	0.26	0.00	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	83.15	6.16	3.08	18.48	6.16	3.08	6.16	0.00	0.00	0.00
tongue, adult	10203-103F5	37.68	3.49	1.63	3.72	1.16	0.70	1.16	1.40	0.93	0.23
tongue, fetal, donor1	10059-101H5	94.19	4.73	5.52	14.98	4.34	2.36	0.79	1.18	0.39	0.00
tonsil, adult, pool1	10047-101G2	44.28	8.21	4.31	6.41	3.61	1.20	0.80	1.10	0.40	2.00
trachea, adult, pool1	10029-101E2	33.54	6.22	2.70	4.34	1.96	1.06	1.80	0.90	0.41	0.33
trachea, fetal, donor1	10058-101H4	108.87	11.54	3.46	7.69	3.08	3.46	0.38	0.77	0.77	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	47.83	10.98	8.50	1.77	1.06	1.42	1.06	0.35	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	6.08	0.51	0.41	0.51	0.20	0.00	0.10	0.10	0.00	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	32.90	3.92	3.92	3.45	2.04	1.25	0.78	0.78	0.31	0.00
tridermal teratoma cell line:HGRT	10694-109G1	79.91	9.51	3.81	3.81	7.61	0.00	0.00	0.00	3.81	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	20.40	4.23	2.88	2.45	2.03	0.59	0.51	0.08	0.08	0.17
umbilical cord, fetal, donor1	10057-101H3	108.50	6.26	4.17	14.61	4.17	0.00	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	43.00	4.27	7.00	8.19	1.02	0.17	2.05	2.73	0.17	0.34
uterus, fetal, donor1	10055-101H1	82.93	7.17	7.17	10.75	1.02	0.51	1.54	0.51	0.51	0.00
vagina, adult	10204-103F6	74.31	12.92	7.75	7.75	4.52	0.00	4.52	1.94	0.00	1.29
vein, adult	10191-103E2	44.06	6.14	4.38	3.95	2.41	0.66	0.44	1.10	0.00	1.53
xeroderma pigentosum b cell line:XPL 17	10563-108A5	13.62	3.47	1.87	3.20	3.47	0.80	0.00	0.27	0.00	0.00